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Mycotoxins are low-molecular-weight natural products produced, as secondary metabolites, by 
filamentous fungi. These molecules represent a wide chemical group with different toxicity effects in 
human and other animals. 
These toxins can accidentally occur in food and feed, due to a direct or indirect contamination.  
The aim of this work was to develop a method for the first time to quantitatively determine 
zearalenone and its metabolites (α-zearalenol, β-zearalenol, α-zearalanol, β-zearalanol, zearalanone) in 
bovine and human hair using LC-MS/MS.  
Once the method was set-up for bovine hair, it was successfully validated according to Decision 
657/2002/CE on three analytes, with satisfying performances. Moreover the applicability of the 
method was tested on human hair in a one-day validation with reasonable performances.  
This method could be a useful tool to evaluate natural feed contamination or detect illegal use of α-
zearalanol in bovines and to perform a first inventory of the occurrence of these molecules in bovine 
and human hair, as biomarkers for zearalenone exposure in future studies. 
Another purpose of this work was to make a preliminary screening on mycotoxins contamination 
(aflatoxin B1, aflatoxin B2, aflatoxin G1, aflatoxin G2, deoxynivalenol, zearalenone, fumonisin B1, 
fumonisin B2, ochratoxin, T-2 toxin and HT-2 toxin) in different pet food types for cats. 
This research showed that mycotoxin occurrence in pet food for cats can represent an issue to put 
under control. Since pets are fed with the same type of pet food for long periods of their life, the 
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1. GENERAL INTRODUCTION 
 
Mycotoxins are low-molecular-weight natural products (250 to 720 Da) produced as secondary 
metabolites by filamentous fungi belonging to the phylum Ascomicota and mainly to the genera 
Aspergillus, Penicillium and Fusarium (Bennett et al. 2003; Brera et al. 2008; Botana & Sainz 2015; 
Alshannaq & Yu 2017). These molecules represent a chemically and toxigenically diverse 
category: they are brought together because the members are cabaple of causing disease and 
death in human beings and other vertebrates (Bennett et al. 2003). 
Moreover they are extrinsic antinutrition factors that can accidentally contaminate feed and food. 
They are responsible for non-contagious and non-infectious pathologies known as 
mycotoxicosis (Nebbia 2009).  
The word mycotoxin stems from the Greek word ‗‗mycos‘‘, meaning mould and the latin ‗‗toxicum‘‘ 
meaning poison: the term was coined in 1962 in the aftermath of an unusual veterinary crisis 
nearby London, called ―Turkey X disease‖, that caused the death of 100.000 turkeys which had 
been fed a batch of peanut meal contaminated with Aspergillus Flavus spores (Bennett et al. 2003). 
However the problem of mycotoxins does not represent a new issue and has probably 
influenced the history and health of peoples more than we thought (Brera et al. 2008). 
Some researchers hypothesize that plagues described in the Old Testament could be attributable 
to this extent, which afflicted Egyptians between 1250 and 1300 B.C: reasonably some of them 
could be related with the ingestion of cereals contaminated by mycotoxins, resulting in lethal 
disease.  
The Middle Ages and the following centuries were characterised by epidemics of ergotism, which 
hit various populations in Central and North Europe: at the time, it was considered a 
transmissible infectious disease. Subsequently it was ascertained that the pathogenesis of this 
disease was caused by ergotamine, a vasoconstrictor alkaloid produced by the Claviceps purpurea 
(rye ergot fungus) that contaminated cereal grains (Peraica et al. 1999; Piva et al. 2006). 
Ergotism is also known as ignis sacer or St. Anthony‘s fire because, at the time, it was believed that 
a pilgrimage to the shrine of St Anthony would have provided relief from the severe burning 
sensation experienced. Moreover people affected by ergotism were exposed to lysergic acid 
diethylamide (LSD), a hallucinogen produced during the baking of bread made with flour 
contaminated by ergot (Peraica et al. 1999). 
In conclusion, although it is plausible to debate that mycotoxins could have represented a 
relevant role in some of the animal and human diseases since the Roman era, the scientific 
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interest for their impact for animal and human health began only in the 1960s (Brera et al. 2008).  
A famous painting of the Flemish painter Pieter Bruegel the Elder (1525-1569), "The beggars" 
illustrates the devastating effects ergotism such as seizures, pains at limbs extremities, gangrene 
and deaths (Bennett et al. 2003; Piva et al. 2006). 
Mycotoxins contamination is influenced by a broad range of climatic conditions. Furthermore it 
is estimated by the Food and Agriculture Organization (FAO) that the 25% of the world crops 
are affected by these contaminants: this phenomenon plays a significant economic impact not 
only for farmers and breeders, but also for the entire agri-food sector and national economies 
(Aidoo 2011). 
Thus mycotoxins represent the hazard category with the highest number of border rejections 
reported by the Rapid Alert System for Food and Feed (RASFF) (Arroyo-Manzanares et al. 
2014). 
The fungi producing mycotoxins in food are divided into two groups: those which infest before 
harvest, commonly described as field fungi, and those which colonise the plant only after 
harvest, considered storage fungi. Thus there are three categories of toxicogenic field fungi: 
those which infest stressed or senescent plants, such as Fusarium moniliforme (fumonisin) and 
sometimes Aspergillus flavus (aflatoxin); plant pathogens such as Fusarium graminearum (nivalenol, 
deoxynivalenol); finally those that invade the plant before harvest and make them prone to 
mycotoxin contamination after harvest, such as Aspergillus flavus (aflatoxin) and Penicillium 
verrucosum (ochratoxin) (Ayalew 2010). 
Animals fed vegetable matrices contaminated with toxic fungi are exposed to significant health 
risks; the same consequences may affect human health (Milani 2013). 
Mycotoxins are molecules of fungal origin, while not all toxic compounds produced by fungi are 
considered mycotoxins. The concentration and the target of the metabolite are both crucial 
factors to take into account. 
These contaminants are toxic to animal groups and vertebrates at low concentrations; while 
other low-molecular weight fungal metabolites, such as ethanol, are not regarded as mycotoxins 
because they exert toxicity only in high concentrations. 
Moreover fungal products that are noxious to bacteria, such as penicillin, are usually described as 
antibiotics, while others that exert toxicity to plants are considered phytotoxins. Additionally, 
even if mushroom poisons are thought fungal metabolites that can provoke disease and death in 
humans and other vertebrates, they are kept out the field of mycotoxicology. The difference 
between a mushroom poison and a mycotoxin relies on the size of the producing fungus, but 
also on human intention. Mycotoxin contamination is almost always unintentional; on the 
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contrary, mushroom poisons can be served and consumed by people who had misidentified as a 
delectable species (Bennett et al. 2003). 
 
 
1.1 MYCOTOXIN  PRODUCTION 
 
The production of secondary metabolites produced by fungi is closely influenced by many 
factors of different nature. 
Essential factors influencing mycotoxin production involve both environmental influences 
(temperature, climate changes, activity water, humidity, mechanical damage of kernels caused by 
pest and insects attack), both plant stress (lack of a balanced nutrient absorption and the extreme 
soil dryness) (Brera et al. 2008). 
These aspects can affect cereals cultivation, harvesting, drying and storage (Frisvad 1995; 
Wicklow 1995). 
Mycotoxin formation in agricultural crops can happen at different stages in the food chain: at 
pre-harvest, harvest, drying, and storage. Inappropriate agricultural and harvesting actions, such 
as incorrect drying, handling, storage, packaging and transport conditions can stimulate fungal 
growth, enhancing the risk of mycotoxin production. Another key element to take into account 
relies on monitoring storing conditions, in order to prevent fungal contamination and mycotoxin 
production (Marin et al. 2013). Thus activity water is the key parameter to check: it represents 
the bioavailability of water in a food, although it would be better to use the percentage humidity 
value as an indicator to describe water content in a feed (Bryden 2012). However, when activity 
water of the stored products reaches levels that can allow fungal growth and mycotoxin 
production, toxins can also colonise processed products (Marin et al. 2013). 
In the growing phase of plants such toxins are produced from saprophytic mushrooms, while 
during storage process they are produced by endophytic fungi (Hussein & Brasel 2001). 
Moreover temperature and humidity are the most important factors for moulds and mycotoxins 
development. The critical levels for mushroom growth are 70-150 g / kg of moisture (depending 
on the raw materials) and a relative humidity of 80-85% (Bryden 2012). 
Temperatures which promote mycotoxins production range from 0 ° C to 35 ° C, depending on 
the fungal species (Milićević et al. 2010). 
Crops infection from fungi can occur in a range of optimal environmental conditions such as 
temperature, relative humidity and rain. These factors can also influence the colonization, toxin 
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production and survival. In addition climate change is expected to promote changes in fungal 
population and mycotoxin patterns leading to a superior mycotoxin contamination of crops 
(Miraglia et al. 2009; Paterson & Lima 2011; Marroquín-Cardona et al. 2014; Medina et al. 2014). 
However the complexity of mycoflora interaction to each crop and to the environment does not 





Although more than 300 mycotoxins exist the scientific research has been converged only to 
approximately ten compounds, which present relevant toxicological impact on animal and 
human health (Brera et al. 2008). 
In Table 1 are reported main important mycotoxins belonging to different genera, such as 









•  Aflatoxins B1, B2, G1,G2, M1 (AFB1, AFB2, AFG1, AFG2, AFM1). 
Fusarium 
•  Trichothecenes: deoxynivalenol (DON), nivalenol (NIV), T-2 and HT-2 
toxin, diacetoxyscirpenol (DAS);  
•  Fumonisins B1, B2, B3 (FB1, FB2, FB3); 
•  Zearalenone (ZEA). 
Penicillium 
•  Ochratoxin A, B, C (OTA, OTB, OTC); 




Aflatoxins (AFs) are generated mainly by Aspergillus parasiticus and Aspergillus flavus, they can 
colonise different feed and food crops, together with Aspergillus nomius and Aspergillus 
pseudotamarii (Kurtzman et al. 1987; Ito et al. 2001). Hot and humid areas, such as tropical and 
subtropical ones, are considered the most susceptible ones to Aspergillus infection and aflatoxin 
contamination (Van der Fels-Klerx et al. 2016). 
Temperatures above 25°C and humidity higher than 85% can promote the growth of aflatoxin-
producing fungi during storage (Brera et al. 2008). 
Aflatoxins are crystalline substances, soluble in moderately polar organic solvents (methanol, 
chloroform, dimethysulfoxide); on the contrary they scarcely soluble in water (10-30 mg/mL) 
and insoluble in non-polar organic solvents. Aflatoxins in a dry state show stability to heat up to 
their melting point.  
Pure aflatoxins are destroyed by UV radiations, are unstable below pH 3 and above pH 10, and 
are susceptible to oxidizing components (Brera et al. 2008). 
Aflatoxins M1 and M2, aflatoxin -hydroxilated metabolites can occur in milk and derived 
products due to the quick biotransformation of aflatoxins B1 and B2 (AFB1, AFB2) in animals 
fed contaminated feeds (Brera et al. 2008). 
Aflatoxins are molecules chemically similar to difuranocoumarin and can be categorised in two 
classes based on their chemical structure (table 2):  
 the difurocoumarocyclopentenone group (AFB1 and AFB2); 
 the difurocoumarolactone group aflatoxin G1 (AFG1), aflatoxin G2 (AFG2) and 











Table 2. Aflatoxin classes based on chemical structure. 
Difurocoumaro- 









B Group G Group 
 6 
The G group is characterised by a D-lactone ring, while the B group contains a cyclopentenone 
ring, which makes them the most toxic group (Figure 1). 
Aflatoxins fluorescence is strong in UV light (ca. 365 nm): AFB1 and AFB2 are characterised by 
a blue fluorescence, while AFG1 and AFG2 by green fluorescence (Brera et al. 2008) 


















Figure 1. Aflatoxin B1 (AFB1), aflatoxin B2 (AFB2), aflatoxin G1 (AFG1), 





Trichothecenes (Figure 2) are a broad class of about 150 mycotoxins generated by different 
species of various fungi of genera: Fusarium, such as Fusarium poae, Fusarium langsethiae and 
Fusarium sporotrichioides; Stachybotrys, Myrothecium, Cephalosporium, Trichoderma, Trichothecium and 
Verticimonosporium (Grove 1988; Smith et al. 1995; Thrane et al. 2004). These molecules present 
chemical similarities, infact they contain a basic group which consists of a common tetracyclic, 
sesquiterpenoid 12,13-epoxytrichothec-9-ene ring, the epoxide group that displays toxicity. 
Trichothecenes are categorised as group A and B, based on the presence of a side chain on C7 
position: T-2 and HT-2 toxin and DAS belong to group A, while main trichothecenes of group 
B comprise deoxynivalenol (DON) (Figure 2), also known as vomitoxin, nivalenol (NIV), 3- and 
15-acetoxy NIV and fusarenon X. They show chemical stability and can persist for long time 
once formed.  
Type A trichothecenes (such as T-2 toxin, HT-2 toxin, DAS) show high solubility in ethyl 
acetate, acetone, dichloromethane, chloroform, and diethyl ether. Type B trichothecenes (such as 
DON, NIV, 3-acetylDON, 15- acetylDON) are relatively polar, highly hydroxylated and soluble 
in acetonitrile, methanol, and ethanol. DON shows one primary and two secondary hydroxyl 

















Moreover T-2 toxin and HT-2 toxin are produced by F. poae, F. acuminatum and F. sporotrichioides, 
which usually occur in different cereal crops (maize, wheat, oats, barley and rye) and processed 
grains (malt, bread and beer) (Figure 2).  
T-2 and HT-2 toxin can colonise together infected cereals in almost all their growing areas in the 
world (Brera et al. 2008). DON represents the prevalent trichothecene of concern in Europe, 





These molecules comprise a family of 28 members; they were characterised for the first time by 
Bezuidenhout in 1988 as a new class of mycotoxins that had been purified from Fusarium 
moniliforme coltures (Bezuidenhout et al. 1988). They are mainly generated by Fusarium proliferatum. 
Fusarium verticillioides (Sacc.) Nirenberg (former F. moniliforme Sheldon) (Geens et al. 2010).  
Fumonisin B1 contains a diester of propane-1, 2, 3 - tricarboxylic acid and 2-amino-12, 16-
dimethyl-3, 5, 10, 14, 15-pentahydroxyeicosane. Moreover, it is the most toxic and abundant one, 
accounting for 70–80% of the total FBs produced (Figure 3) (Friend et al. 1983; Gelderblom et 
al. 1988; Rheeder et al. 2002). 
Fumonisin B2 (FB2) (Figure 3) is a deoxy-analogue of FB1, representing the 15-25% of total 
FBs. 
Instead fumonisins B3 (FB3) stereochemistry is still unknown. However, the amino terminal of 
FB3 possesses the same configuration as that of FB1. MoreoverFB3 usually constitutes the 3- 
8% when cultured on rice, corn or in liquid medium. 
Fumonisins pure substance is a white hydroscopic powder which displays solubility in water, 
acetonitrile-water or methanol. Fumonisins are soluble in polar solvents due to their four free 
carboxyl groups, the hydroxyl groups and the amino group. In addition they show insolubility in 










ZEA (Figure 4) is a non-steroidal phenolic resorcyclic acid lactone estrogenic toxin generated 
mainly by Fusarium culmorum, Fusarium graminearum and Fusarium sacchari. This mycotoxin with its 
main metabolites will be further described in the next chapter. This compound is a white 
crystalline one that displays solubility in water, slightly solubility in hexane and progressively 
higher solubility in acetonitrile, benzene, dichloromethane, ethanol, methanol and acetone.  
 
Figure 4. Zearalenone (ZEA) structure. 
 
It also shows blue-green fluorescence when excited by long wavelength UV light (360 nm) and a 
more intense green one when excited with short wavelength UV light (260 nm) (Diekman & 
Green 1992; Brera et al. 2008). 
Its presence is commonly related to DON production. The contamination of food and animal 
feeds occurs at a global scale, such as in maize, wheat, barley, soya, oat, beer, vegetables, dried 





Ochratoxins A (OTA), B and C (Figure 5) are formed by a pentaketide derived from the 
dihydrocoumarins family coupled to -phenylalanine. 
OTA, the most harmful and relevant toxin, is characterised by a chlorine atom on the aromatic 
ring, which is responsible for its toxicity. It is a colourless crystalline substance which exhibitis 
blue fluorescence under UV light. In neutral and acidic pH OTA is soluble in polar organic 
solvents (alcohols, chloroform, ketones), slightly soluble in water and insoluble in petroleum 
ethers and saturated hydrocarbons (el Khoury & Atoui 2010). 
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Aspergillus ochraceus is considered the main OTA producer, especially in cereals grown in warm 
climate. Moreover also other species of Aspergillus section Circumdati, Aspergillus steynii and 
Aspergillus westerdijkiae represent the most important fungi producers (Gil-Serna et al. 2015).  
The optimal temperature for Aspergillus ochraceus which allows ochratoxins production ranges 
from 25 to 30 °C. Because of the broad range of fungi able to produce OTA, this molecule has 
been reported to colonise different areas of the world, in particular temperate climates, mainly in 
in various food products such as cereals, cocoa, coffee, wine (Sanchis & Magan 2004; Paterson 
& Lima 2011; Van der Fels-Klerx et al. 2016). 
 
 








1.3 EXPOSURE AND  HEALTH  EFFECTS 
 
Food product contamination can occur as a consequence of a carry over from contaminated 
feed and can be present in food of animal origin such as eggs, milk and meat. Although some 
technological processes are able to lower mycotoxins levels of the raw commodity, processed 
food (beer and wine) can also shows contamination due to the use of contaminated raw material. 
Thus it is important to take into account that mycotoxins are resistant towards high temperatures 
and also cooking procedures, which are not able to destroy them (Brera et al. 2008). 
Moreover humans and animals can also be exposed to these contaminants by inhalation of 
contaminated dusts. This phenomenon can occur both in certain working places such as in 
harbours, both in domestic environments due to the indoor contamination caused by wallpapers 
and mouldiness (Brera et al. 2008). 
Mycotoxin ingestion can cause both acute and chronic toxicities: the former is characterised by a 
quick onset and toxic effects; the latter is resulted from low-dose exposure to these molecules 
over a long period of time, with adverse effects (hepatotoxicity, nephrotoxicity, neurotoxicity, 
immunosuppression, oestrogenicity, teratogenic, mutagenic and carcinogenic effects) (Malir et al. 
2006; Wild & Gong 2009; Kensler et al. 2011). 
Clinical symptoms usually regress when exposure from contaminated food or feed is ceased 
(Hussein & Brasel 2001). 
In 1993 the International Agency for Cancer Research assessed the potential carcinogenic effect 
of the main mycotoxins (IARC 1993).  
Aflatoxins can generate both acute toxicity and chronic carcinogenicity in human and animal 
populations. AFB1 is classified by (IARC) as a Group 1 carcinogen, inducing high risks for 
hepatocellular carcinoma (HCC) in people exposed to aflatoxins, while AFM1 is listed in Group 
2B (possibly carcinogenic to humans) (Bennett et al. 2003). 
In humans acute aflatoxicosis can cause vomitting, abdominal pain, coma, convulsions, and even 
death, while in animals can generate anemia, lowered milk and egg production, gastrointestinal 
dysfunction, reduced reproduction rate, lowered feed conversion and efficiency (Alshannaq & 
Yu 2017). 
Trichothecenes were responsible causing alimentary toxic aleukia (ATA) toxicosis in the USSR in 
1932. IARC placed DON in Group 3 Carcinogenesis: this molecule can be associated with 
nausea, vomiting, abdominal pain and diarrhea in humans. Moreover this class of contaminants 
can also cause also toxic effects in animals such as slow growth, intestinal hemorrhage, lowered 
milk production in cattle and drop in egg production in laying hens. 
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Fumonisin B1 has been classified as probably carcinogenic in 2B Group by IARC: fumonisins 
can cause severe toxicity on animals, and can exert toxic effects in kidney and liver.  
Because of their hydrophilicity low amount of FB1 can accumulate in edible tissues (Richard 
2007; Ostry et al. 2017). 
Zearalenone is classified as a Group 3 carcinogen by IARC. Since ZEA is characterised by a 
strong estrogenic activity, due to the competitive binding to estrogen receptors, it can induce 
estrogenic effects both in human and animals. It can provoke significant alterations in laboratory 
and domestic animals such as infertility, hyperestrogenism, reduced milk production in cattle 
(Alshannaq & Yu 2017). This aspect would be further discussed in the next chapter. 
Ochratoxin A is classified by IARC in Group 2B (possible human carcinogen) and it also 
interferes RNA and DNA synthesis. OTA is linked with acute nephrotoxicity and hepatotoxicity, 
and it can generate immunotoxicity, neurotoxicity, genotoxicity, teratogenicity, and 
embryotoxicity in both human and animals. It can also impact the productivity of food 
producing animals such as lowering feed conversion and body weight gain, decreasing egg 
production in laying hens. Since OTA is fat soluble it can accumulate into animal tissues, 
especially in pigs (Mantle 2002; Stoev et al. 2002; Heussner & Bingle 2015).  
Animal and human health risks have been subject to a re-examination over the last few years: 
factors which affect the extent of toxicity include mechanisms of action and metabolism which 
are specific to each mycotoxin (De Liguoro 2006).  
Metabolism and defense mechanisms are important aspects that help to better understand 
species-specific and individual toxicity. The role of species-specific mechanisms has been 
demonstrated by deeply examining the existing metabolic differences between ruminants and 
non-ruminants: the former seem to be more resistant to adverse effects of mycotoxins. In vitro 
studies showed the degradative capacity of ruminal flora towards these contaminants (Hussein & 
Brasel 2001). 
These contaminants have attracted worldwide attention because the huge impact on human 
health and economic losses derived from contaminated foods (Ostry et al. 2017). 
The presence of mycotoxins in zootechnical feeds, based on their concentration, can cause 
mycotoxicosis with subclinical manifestations relatively frequent but not easy to diagnose; while 
forms with clear clinical manifestations are rather rare and easier to diagnose, manifesting 
impairments of specific target organs (De Liguoro 2006). In the field of animal husbandry some 
toxic effects of mycotoxins are complex to detect, particularly the carcinogenic ones due to the 
short life span of livestock animals. There are other toxic effects occuring in animals fed 
contaminated feed at low concentrations of mycotoxins, such as hemorrhagic fever in poultry 
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meat, or liver degeneration in pigs caused by fumonisins which can alter the final food product 
(De Liguoro 2006). 
It is important to point out that any animal species can be damaged not only by high exposure to 
mycotoxins but also at low levels of contamination. As previously described animals with highly 
active ruminal flora are less sensitive to mycotoxins because of the degradative action these 
microorganisms exert towards these contaminants. Instead pig species, rabbit, chicken show a 
high sensitivity to the main mycotoxins.  
 
 
1.4 PREVENTION  AND DECONTAMINATION  
STRATEGIES 
 
In recent years many efforts have been made to prevent the onset of the main mycotoxins. 
European legislation highlighted the necessity to develop prevention systems and effective 
diagnostic tools in order to counter this issue. 
In this regard, various studies have been carried out in the light of the Hazard Analysis Critical 
Control Point (HACCP) approach, which allows the identification of critical control points 
(CCPs) in any process relating food production (Magan 2006). 
As previously described mycotoxins can colonise at pre-harvest, harvest and post-harvest phases. 
Therefore many key aspects can be performed in order to reduce mycotoxin contamination. Pre-
harvest management is the optimal way for preventing mycotoxin contamination. The main 
effective actions include: 
 a proper management of insect infestation (because damaged kernels can determine 
favourable conditions for growth of mould species); 
 a correct management of crop rotation and residues; 
 a suitable irrigation strategy to avoid drought or excessive moisture of soil; 
 the use of naturally resistant plant varieties to fungal infection.  
The genetic engineering research, pursued with the enhancement or addition of antifungal genes, 
is still in debate and a controversial issue, linked with ethic, economic, environmental aspects 
(Brera et al. 2008). 
Procedures involving the avoidance of damaging kernels, effective drying processes should be 
taken into account during harvesting phase. These methods are essential to reduce mycotoxin 
production during storage. Some studies showed that crops left on the field for longer time may 
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generate higher levels of toxin contamination. Decontamination techniques for lowering or 
eliminating mycotoxins in food products have not yet been standardized worldwide due to the 
scarce results or high costs (Brera et al. 2008). 
In this regard only few of decontamination techniques have been found effective such as the use 
of physical and chemical methods in post-harvest prevention systems. 




 UV radiation;  
 ultrasonic treatment; 
 thermal treatment. 
 
The efficiency of these techniques relies on the level of contamination and distribution of the 
raw material (Kolosova & Stroka 2012). 
Moreover the use of chemical methods also requires sample preparation treatments, which make 
them laborious and expensive. In this sense numerous chemicals have been tested, such as 
oxidizing and reducing agents, acids, bases and salts for their ability to degrade mycotoxins; 
however only few of them allowed preservation of the nutritional properties. 
Furthermore neither the use of chemical decontamination processes or batches blending (with 
the aim of reducing the level of contamination below the maximum tolerable level), are 
considered legal procedures in the European Union (Kolosova & Stroka 2012). 
Recent studies allowed to develop strategies reducing mycotoxin contamination, so-called 
"mycotoxin binders". These molecules, if intentionally added to feed, are able to inhibit the level 
of such contaminants in in vivo animals. The use of adsorbent substances is authorized by the 
European Union, as they fall into the category of zootechnical additives (European Community 
2003).  
Some researchers, however, recommend the administration of these substances only 
occasionally, since these materials may also adsorb micronutrients and diminish the availability of 
essential nutrients, adsorpting the mycotoxins in the gastrointestinal tract and preventing 
distribution into target organs. The effectiveness of these binding substances seems to rely on 
involved actors: binders and mycotoxins. Therefore the physical structure of the adsorbent 
agent, the distribution of charges, the pore size and contact surface content are relevant aspects. 
However the intrinsic characteristics of mycotoxins also play a significant role, such as polarity, 
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solubility, shape, and charges distribution. Examples in this regard are provided by active 




The first food regulation in history was enacted approximately 3500 years ago by a king of the 
Hittites, in the area that nowadays corresponds to Turkey. This law already dealt with health 
protection and fraud prevention (Van Egmond HP 2013). 
The awareness that mycotoxins can cause harmful effects both on humans and animals 
encouraged many countries to promote regulations on mycotoxins in feed and food in order to 
protect human health, as well as the businesses of producers and traders (FAO 2003). 
In this regard there are specific aspects such as the availability of toxicological information, 
knowledge about mycotoxin distribution in foods, occurence in different commodities, 
availability of methods of analysis, political and economic aspects that should be taken into 
account (Van Egmond et al. 2007). 
Establishing mycotoxin regulations represents a complex activity, which concerns many aspects 
and different stakeholders. Harmonisation of mycotoxin regulations in food and feed started 
from the 2000‘s in many areas such as the EU (European Union), COMESA (Common Market 
of Eastern and Southern Africa), Australia, New Zealand, MERCOSUR (Mercado Comun del 
Sur), GCC (Gulf Cooperation Council) and ASEAN (Association of South East Asian Nations) 
(Van Egmond 2013). 
At least 99 countries in 2003 put specific limits for mycotoxins in both feedstuffs and foodstuffs, 
an increase of 30% compared to 1995 (Van Egmond et al. 2007). 
Risk assessment is one of important process which leds to establish relevant mycotoxin 
regulations. Thus risk assessments have been carried out by many international and national 
public health and governmental authorities such as the European Food Safety Authority (EFSA), 
US Food and Drug Administration (FDA), JECFA (FAO/WHO Joint Expert Committee on 
Food Additives and Contaminants).  
Risk assessment focuses on various aspects such as hazard identification, hazard characterization, 
exposure assessment and risk characterization. 
While risk assessment is mainly carried out by scientific committees, risk management is 
conducted by regulators and policy makers. Finally risk communication is mediated by risk 
assessors and managers, and the stakeholders (FAO 2003; Van Egmond 2013; Alshannaq & Yu 
2017). 
Hazard identification, that represents the indication that a substance can provoke adverse effects 
on health, is usually part of the information showed to JECFA for evaluation. 
In the same way hazard characterization, which relies on the quantitative and qualitative 
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evaluation of the adverse effects, is part of the data that are presented. Moreover the evaluation 
of toxicological data performed by JECFA can be needed estimating a Provisional Tolerable 
Weekly Intake (PTWI) or a Provisional Tolerable Daily Intake (PTDI) (FAO 2003). 
The term ―provisional‖ states the uncertained quality of the evaluation in view of the sparsity of 
reliable data about the consequences of human exposure at levels which JECFA is concerned. 
As a matter of principle, the evaluation is based on the characterisation of a No-Observed-
Adverse-Effect-Level (NOAEL) in toxicological studies and the application of an uncertainty 
factor. The latter one is obtained dividing the lowest NOAEL in animal studies by 100, 10 for 
extrapolation from animals to humans and by 10 for variation between individuals, in order to 
formulate a tolerable intake level.  
In cases where the data are scarce, JECFA utilises a higher safety factor (FAO 2003). In table 3 
















Table 3. Tolerable daily intakes of main mycotoxins. TWI: tolerable weekly intake;  
TDI: tolerable daily intake; ALARA: as low as reasonably achievable; bw: body weight. 
 
 
European Commission (EC) set maximum allowed levels and recomedations for many 
mycotoxins in food (Commission Regulation 2006; Commission Recommendation 2013) and 
feed (Commission Directive 2003; Commission Recommendation 2006; Commission 
Recommendation 2013) among its Member States.  
Guidance values and maximum levels for mycotoxins in animal feed have been established in 
Commission Directive 2003/100/EC and Commission Recommendation 2006/576/EC (Table 
4 and 5) (Pinotti et al. 2016).  
Methods of sampling and analysis have been set for the official control of the levels of 
mycotoxins in foodstuffs by Commission Regulation (EC) number 401/ 2006.  
Mycotoxins Tolerable Daily Intakes 
Aflatoxin B1 ALARA 




T-2 and HT-2  
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Regulations are also established by the US Food and Drug Administration.  
In the late 1960s were set the first limits for aflatoxins, approximately ten years after the 
discovery of these contaminants: AFs have been closely controlled by the FDA since 1969. 
Among all mycotoxins, AFs are the only one provisioned by FDA; while others are regulated 
only by advisory levels (FAO 2003; Van Egmond 2013; Alshannaq & Yu 2017). 
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Table 4. Maximum levels for mycotoxins in cereals and cereal products for human consumption (Commission Recommendation No 2013/165/EU and  



















(*) indicates Recommendation.   





All cereals and all products derived from cereals  
Maize to be subjected to sorting or other physical treatment before human consumption or use as an 
ingredient in foodstuff 
2.0 
5.0 
Aflatoxins, sum of B1, B2, 
G1 and G2 
All cereals and all products derived from cereals  
Maize to be subjected to sorting or other physical treatment before human consumption or use as an 





Unprocessed cereals other than durum wheat, oats and maize   
Unprocessed durum wheat and oats  
Unprocessed maize, with the exception of unprocessed maize intended to be processed by wet milling Cereals 








Unprocessed cereals other than maize  
 Unprocessed maize with the exception of unprocessed maize intended to be processed by wet milling  
Cereals intended for direct human consumption, cereal flour, bran and germ as end product marketed for 
direct human consumption  








Unprocessed cereals  
All products derived from unprocessed cereals, including processed cereal products and cereals intended for 
direct human consumption 
5.0 
3.0 
Fumonisin B1 + B2 Unprocessed maize, with the exception of unprocessed maize intended to be processed by wet milling Maize 









Sum T-2 and HT-2 toxin(*) 
Unprocessed cereals 
Barley and maize   
Oats   
Wheat, rye and other cereals  
Cereals grains for direct human consumption  
Oats   











Table 5. Maximum levels and guidance levels for mycotoxins in products intended for animal feed (Commission Directive 2003/100/EC, Commission      
             Recommendation 2016/1318/EC, Commission Recommendation No 2013/165/EU). Adapted and modified from Pinotti et al. 2016. 
 
 
Mycotoxin Cereal and Cereal Products Maximum Levels, mg/kg 
Aflatoxin B1(*) 
 
All feed materials   
Complete feedstuffs for cattle, sheep and goats with the exception of:  
Complete feedstuffs for dairy animals   
Complete feedstuffs for calves and lambs   
Complete feedstuffs for pigs and poultry (except young animals)   
Other complete feedstuffs   
Complementary feedstuffs for cattle, sheep and goats (except Complementary feedstuffs for dairy animals, calves and lambs)  
Complementary feedstuffs for pigs and poultry (except young animals)  
Other complementary feedstuffs  











Deoxynivalenol Feed materials  
Cereals and cereal products with the exception of maize byproducts  
Maize byproducts   
Complementary and complete feedstuffs with the exception of:   
Complementary and complete feedstuffs for pigs   












Feed materials  
Cereals and cereal products with the exception of maize byproducts   
Maize byproducts  
Complementary and complete feedstuffs  
Complementary and complete feedstuffs for piglets and gilts (young sows)   
Complementary and complete feedstuffs for sows and fattening pigs   
Complementary and complete feedstuffs for calves, dairy cattle, sheep (including lambs) and goats (including kids)  
Compound feed for: 










Ochratoxin A Feed materials(*) 
Cereals and cereal products(**) 
Compound feed for: 
pigs 
poultry 








Mycotoxin Cereal and Cereal Products Maximum Levels, mg/kg 
Fumonisin B1 + B2 Feed materials 
Maize and maize products   
Complementary and complete feedstuffs  
Pigs, horses (Equidae), rabbits and pet animals   
Fish   
Poultry, calves (<4 months), lambs and kids   








Sum T-2 and HT-2 toxin Compound feed for cats                    0.05 
 















In this regard EU set limits for ZEA and OTA in several foodstuffs (Commission Regulation 
2006), while the US FDA did not put any regulatory guidelines for those molecules (Alshannaq 
& Yu 2017). 
Moreover European Union put in place since 1979 the Rapid Alert System for Food and Feed 
(RASFF) which are harmful to human health. This system is based on a rapid information 
exchange among the authorities of the Member States, EFSA and European Commission. 
In the case of problems in the food chain RASFF carries out the effective measures in order to 
safeguard the consumer safety (Van Egmond 2013). 
From the 1st January 2017 to 1st December 2017 484 mycotoxin notifications were reported 
from food and 24 notifications in feed in the RASFF portal (RASFF 2017). 
 
 




The distribution of mycotoxin is a relevant factor to take into account in establishing regulatory 
sampling criteria. The distribution of contaminants can be heterogeneous. Mycotoxin 
concentration in an inspected batch can be wrongly assessed if appropriate procedures for 
representative sampling are not implemented (Barkai-Golan & Paster 2008).  
Sample variation is a relavant error in estimating concentrations of mycotoxins in batches 
commodities. Mycotoxin concentrations display a distorted or uneven distribution in feed and 
food, particularly in whole kernels (or nuts). Therefore it is difficult to collect a sample that 
properly reflects the mean batch concentration: this one can be invalidated and it can bring to 
undesirable health and or economic consequences (Whitaker et al. 2010). Even though errors 
can be sometimes unpredictable, it should be considered that most errors are generated from the 
sampling stage rather than sample analysis. Thus 90% or more of errors are caused sampling 
variability as a consequence of the heterogeneity of the matrices (Zhang 2006). 
Certainly the type of matrix to be analyzed can determine different approaches for 
heterogeneous samples (feed, granules) rather than for homogeneous samples (milk, cheese, 
flour); the homogeneity of the sample is a good assumption to obtain a significant sample, 
however not excluding the homogeneity and the representativeness of the batch. Also the 
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amount of sample to be analyzed may vary, so it will be necessary to collect batches in various 
parts and in larger part from heterogeneous samples, while collecting smaller quantities for 
homogeneous samples it will be required (Cast 2003). 
The design of sampling procedures for multiclass mycotoxins and sample materials represented 
an international concern for several years (Krska et al. 2008). 
International and national agencies, such as the European Union (EU), Codex Alimentarius and 
the United States Dept. Agriculture (USDA) have set sampling plans for a broad range of 
commodities. 
Sampling plans defines the batch size (or a representative sub-batch in the case of very large 
lots), the size of the aggregate sample and the minimum number of incremental samples (Turner 
et al. 2015). 
In the European panorama, as far as sampling (and analytical) methods are concerned for the 
official control of the levels of mycotoxins in foodstuffs, EC Regulation 401/2006 has precise 
indications for each type of matrix. 
To obtain comparable data the Regulation 401/2006 (Commission Regulation 2006), directly 
applicable to all Member States, harmonizes in a single legal act the procedures for preparation, 
analytical methods, performance criteria for the official control of mycotoxins. Proper sampling 
it is, in fact, the basic prerequisite for a reliable analytical method: the quantity of sample must be 
as representative as possible of the original lot to be sampled, taking into account the 
distribution of the mycotoxins are very variable depending on the type of sample matrix (Tealdo 
2006).  
Moreover the whole analytical process, which includes sampling, sample preparation, clean-up 
and final determination, used by each laboratory for the enforcement and control of regulatory 
limits, needs to undergo to a validation procedure, in order to show that the method meets the 
prescribed criteria. Thus analytical methods available can be validated and accepted by official 
authorities, such as the European Committee for Standardization (CEN), the Association of 
Official Analytical Chemists (AOAC International) and the International Organisation for 
Standardization (ISO) (Krska et al. 2008). 
Furthermore each laboratory can enforce quality assurance systems checking the precision and 
trueness of their protocols by analysing certified reference materials (CRM) and participating in 
proficiency tests (Krska et al. 2008). 
The European Union Reference Laboratory (EURL) for mycotoxins, together with national 
reference laboratories, monitors and assesses the performance of analytical methods in order to 
ensure a reliable measurement capacity in Europe (De Saeger et al. 2016). 
 25 
RIKILT (Wageningen University & Research) is the Dutch National Laboratory and the EU 
Reference Laboratory for analysis of biological residues produced by food-production animals 
for the presence of hormonal growth promoting compounds, sedatives and mycotoxins. As the 
others EURLs represents the interface between the European Commission (DG SANCO) and 
National Reference Laboratories in the Member States. 
 
 
1.6.2 Analytical Techniques 
 
The mycotoxins issue therefore demands robust analytical methods even though it is not always 
an easy task. The detection and identification of these molecules is often considered as a relevant 
paradigm for the analysis of environmental compounds. The complexity of the target, matrix, 
detection levels, time requirements and availability of suitable technology reprensent a challenge 
for the analytical process (Turner et al. 2015). 
Screening methods are used to reveal the presence of a substance or a class of substances at a 
level of interest: these are methods of election adopted when it is necessary analysing a high 
number of samples in a short time and they are also economic methods with a good sensitivity 
(European Commission 2002). 
Most used screening tests are enzyme immunoassays ELISA, Lateral Flow, polarization 
immunoassay fluorescence (FPIA), immunofiltration assays and, more recently, biosensor assays; 
however, the thin layer chromatography (TLC) is still widely used. 
Lateral flow devices (LFD), also called "strips", are immunochromatographic analytical methods, 
whose reagents are incorporated directly into the device. This feature makes the method suitable 
for on field analysis, they can be used also by untrained personnel. The strips can be less precise 
than other screening methods, but they can be sufficiently sensitive and accurate. 
Among quick methods based on immunochemical techniques that do not require clean-up or 
analyte enrichment steps, ELISAs became common tools for rapid monitoring of most 
mycotoxins, in particular for the screening of raw materials. Although ELISA tests can be 
affected by a high matrix dependence and possible overestimation of concentration levels, the 
benefits are speed, easy to use, good sensitivity and high sample throughput (Krska et al. 2008). 
Furthermore biosensors are becoming more common in different fields (i.e healthcare, 
environmental, food sector): they rely on biological recognition such as enzyme-substrate, 
antibody-antigen or receptor-ligand) and they are connected to a transducer or detection system  
(i.e electrical, optical, acoustic or thermal) (Thakur & Ragavan 2013). 
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On the other hand confirmation methods provide complete information to identify a substance 
in a univocal way and, if necessary, quantify it at certain level of interest (European Commission 
2002). 
In general physico-chemical techniques, i.e separation by gas chromatography (GC), or high- 
performance liquid chromatography (HPLC) coupled with specific detectors are used to obtain 
highly reliable results. The detectors commonly used with these chromatograph techniques are 
flame ionization (FID), ultraviolet (UV), UV diode arrays, fluorescence (FL), electronic capture 
(ECD), and mass spectrometry (MS). 
Currently liquid chromatography coupled with mass spectrometry (LC-MS) is probably the most 
used analytical method for mycotoxins analysis. 
In the last few years technical progress has been made in this sector, allowing the simultaneous 
determination of different classes of mycotoxins (Meneely et al. 2011).  
In comparison to other detection techniques, such as fluorescence or UV, mass spectrometry 
shows higher sensitivity and selectivity (even though fluorescence detection can be more 
sensitive for certain mycotoxins, such as aflatoxins), unequivocal confirmation of the analyte and 
allows the use of isotopically labelled substances as internal standards (Krska et al. 2008). 
Furthermore relevant progress has been made in sequencing the entire genome of mycotoxins 
producing fungi: in which reference databases for genomic, transcriptomics, and proteomics 
analysis in the field of mycotoxin were created. Thanks to biomolecular methods (Real Time 
PCR, Microarray, 2-D DIGE) it is possible to identify the genes responsible for the biosynthesis 
of mycotoxins, their cluster organisation and their epigenetic regulation (Woloshuk & Shim 
2013). 
Because of the complexity of the matrices in which toxins are generally found, a pre-analysis step 
is required for most chromatographic methods, whereas for some immunological methods it 
may be not necessary. Although this step can involve extra cost and can be considered time-
consuming, the improvements in sensitivity and robustness are relevant (Turner et al. 2015). 
Different approaches for extraction and clean-up purification step have been proposed: the most 
popular methodology utilises solid-liquid extraction (SLE) followed by solid phase extraction 
(SPE), often carried out with immunoaffinity columns (IACs), which uses specific antibodies to 
link the analyte of interest (Arroyo-Manzanares et al. 2014). 
SPE is an important support for sample preparation in mycotoxin analysis: there are many solid 
phase, including ion exchange, C18 materials, hollow microfibers and immunoadsorbent materials 
(Turner et al. 2015). 
IACs are based on immobilised antibodies that selectively retain a certain mycotoxin or 
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mycotoxin class: they are characterised by high specificity, producing cleaner extracts and 
lowering interfering matrix components in order to produce excellent signal-to-noise ratios 
compared to less selective SPE sorbent materials. IACs have been developed for most 
mycotoxin classes such as aflatoxins, trichothecenes, ochratoxin A, zearalenone and their 
metabolites (Krska et al. 2008). On the other hand, IACs also represent a complex and expensive 
clean-up system which can be affected by low recoveries for some classes of mycotoxins.  
As a consequence multiclass, simpler extraction systems are often used.  
Among the different methods, the so-called QuEChERS (quick, easy, cheap, effective, rugged, 
and safe) and dispersive liquid-liquid microextraction (DLLME) are becoming the common 
treatments (Arroyo-Manzanares et al. 2014). QuEChERS is an inexpensive and fast method 
widely also used also for the extraction of pesticides: it presents some benefits such as its ease, 
minimum steps, and effectiveness for cleaning up complex matrices. It is based on two steps: the 
extraction and dispersive SPE (dSPE). The first step is based on partitioning via salting-out, 
implying the equilibrium between an organic and an aqueous layer; the second step allows 
further clean-up with combinations of MgSO4 and different sorbents, such as C18 or primary and 
secondary amine (PSA). QuEChERS method is employed for the extraction of multiclass 
mycotoxins in bread, cereal products, eggs, spices.  
DLLME relies on the specific solubility of the target analyte in a ternary component solvent 
system. It is considered the simplest method of pre-treatment available (Turner et al. 2015).  
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2. AIM OF THE THESIS 
 
Mycotoxins are natural contaminants produced by several species of fungi as secondary 
metabolites. They can represent a health risk to humans and animals due to their toxicity and 
occurrence in food and feed. For this reason they have attracted worldwide attention because of 
the huge impact on health, the agri-food sector and national economies. 
The available information regarding their occurrence in foodstuffs and feedstuffs, and harmful 
health effects have recently increased, highlighting the importance of further investigations. 
 
The purpose of the research presented in this thesis was to: 
 
1. develop a method for quantitative determination of mycotoxin zearalenone and its 
metabolites (α-zearalenol, β-zearalenol, α-zearalanol, β-zearalanol and zearalanone) in 
bovine and human hair using LC-MS/MS; 
 
2. determine the occurrence of various mycotoxins  (aflatoxin B1, aflatoxin B2, aflatoxin 
G1, aflatoxin G2, deoxynivalenol, zearalenone, fumonisin B1, fumonisin B2, ochratoxin, 
T-2 toxin and HT-2 toxin) in different pet food for cats using LC-MS/MS. 
 
The first project was conducted at RIKILT, the Institute for Food and Feed Safety 
located in Wageningen (The Netherlands), during a traineeship held between April and 
August 2017. 
The institute is specialised in detecting and identifying substances in food and animal 
feed and determining the functionality and effect of those substances.  
Moreover RIKILT is the National Reference Laboratory (NRL) for monitoring residues 
and contaminants in food and feed, it is also the European Union Reference Laboratory 
(EU-RL) for mycotoxins and hormonal growth-promoting compounds. 
 
The second part was conducted at CABA-Lab (Laboratory of Analytical Bio-
Agroalimentary Chemistry), set in the DIMEVET (Veterinary Medical Sciences 
Department) in Ozzano dell‘Emilia, Bologna University. This laboratory carries out 
research activities in the field of residue and contaminant detection in food and feed and 
provides analytical support for veterinary-biomedical research.   
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3. ZEARALENONE AND METABOLITES  
3.1 PROJECT INTRODUCTION 
 
3.1.1 Hair composition and development 
 
Hair is a keratinized tissue which is produced inside the hair follicle. Its growth comes from 
matrix cells which are located in the bulb region (Shimomura & Ito 2005).  
Hair is a filament protein comprised of terminally differentiated dead keratinocytes, so called 
trichocytes, which form a fibre of massive strength, the hair shaft. Mammals are characterised by 
the presence of hair, which exerts a broad range of functions such as thermal isolation, physical 
protection, sweat and sebum dispersion, sensory and tactile functions and social interactions 
(Schneider et al. 2009). 
Hair shafts originate from the hair follicle (Figure 6), a complex structure in the skin, which 
encompasses the pilosebaceous unit together with other structures such as the sebaceous gland, 
the apocrine gland and the arrector pili muscle (Schneider et al. 2009). 
Bovine hair is made up of over 90% protein, with keratin as the main component (Reniers  & 
Brebbia 2011). 
Depending on its moisture content human hair is composed of 65–95% protein (specifically 
fibrous proteins, which are mostly alpha keratins), 15–35% water and 1–9% lipids, melanins, 
while mineral hair content ranges from 0.25 to 0.95%, based on dry weight (Boumba et al. 2006; 
Kempson & Lombi 2011). 
The structural unit of alpha keratin is composed of three right-handed alpha helical polypeptides 
in a left-handed coil which is fortified by disulfide bonds. The thiol (–SH) group of cysteine is 
highly reactive and will bind another cysteine residue in order to create a disulfide bond (–S–S–), 
forming cystine. These bonds give rigidity, mechanical properties and tertiary structure of the 
protein (Kempson & Lombi 2011). Hair proteins contain amino acids glycine, aspartic and 
glutamic acid, threonine, cysteine and lysine (Boumba et al. 2006). 
Lipid content is derived from secretions and sebum of apocrine glands.  
This fraction is constituted by fatty acids, mono- di- and triglycerides, hydrocarbons, wax esters 
and alcohols. Three phases characterise the human hair lifetime: the anagen, catagen and telogen. 
The first represents the active growth phase of hair: this stage is characterised by rapid division 
of the cells in the bulb of the follicle.  
 30 
Hair formation is based on the elongation of new cells which form a thin filament. Then hair 
cells advance into the follicular canal, differentiating into cuticle, cortex or medulla cells and 
starting the keratinization process. During this step, the hair growth is about 1 cm every 28 days, 
while scalp hair remains in this phase for 2-6 years (Boumba et al. 2006).  
Hair usually grows 0.44 mm per day (ranging from 0.38 to 0.48 mm) for men and 0.45 mm per 
day (ranging from 0.40 to 0.55 mm) for women in the vertex region of the scalp.  
Furthermore the hair growth rate is influenced by anatomical location, gender and age.  
During this growing phase, the capillary blood which is located around the follicle supplies 
nutrients and may deliver also exogenous substances that might be in the blood stream such as 
drugs, trace metals (Boumba et al. 2006). 
Moreover chemicals can be incorporated into hair in the keratinogenous zone thanks to 
surrounding tissues, intercellular or lymph fluids. 
The catagen phase represents a rapid transitional stage that follows the anagen phase, which is 
characterised by interruption of cell division and the fully keratinization of hair shaft.  
This stage lasts for about 2-3 weeks when the follicle becomes considerably shorter. 
Finally telogen is a quiescent or resting phase, in which the growth of the hair shaft stops 
definitely. During this step the root allows hair anchorage into the follicle.  
Then the germ cells below the root will generate the next anagen hair, while the old one will be 
forced out and lost. Scalp hair resting phase is mantained for 10 weeks, while in the rest body 



























Figure 6. Hair longitudinal section, created by A. Repossi. 
  
 
3.1.2 Mechanisms of xenobiotics incorporation into hair 
 
The first case of poison identification in human hair was published into a ‗Practical Guide to 
Legal Medicine‘ by Hoppe in 1858, where he described the arsenic determination in the hair in a 
body exhumed after 11 years. Approximately 100 years later, in 1954 Goldblum determined 
amphetamine content in the hair of a guinea-pig (Sachs 1997). 
In general the uptake of environmental chemicals can happen by three ways: dermal absorption, 
inhalation and ingestion. This phenomenon is influenced by the physical and chemical properties 
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of the substance, together with the exposure time and the individual susceptibility.  
Thus the body burden can be determined by absorption, distribution, metabolism and excretion 
(Esteban & Castaño 2009). 
Chemical properties and individual variability can affect the magnitude of these phenomena and 
the final fate of the xenobiotic, which can be excreted in biological matrices like saliva, urine, 
breast milk or faeces, stored in bones or adipose tissue (Esteban & Castaño 2009). 
Passive transfer represents the simplest model hypothesised for xenobiotic incorporation into 
hair. According to this scheme chemicals are transferred by passive diffusion from the 
bloodstream into hair cells located into the base of the follicle and then following the 
keratogenesis process they bind inside the hair shaft. The incorporation is influenced by the drug 
concentration in blood, which relies on the ingested drug dose. Segmental hair analysis 
represents the scientific base for determining the time course of the xenobiotic, since hair 
growth is assumed to be constant. According to this theory the position of the drugs along the 
hair shaft can be associated with the time the drugs were present in the bloodstream. Thus 
segmental analysis can represent a ―calendar‖ of drug use in an organism (Boumba et al. 2006). 
Many authors have found too many factors that give complexity to associate hair contamination 
to blood concentrations (Kempson & Lombi 2011). 
Hence based on the current state-of-the-art literature, only a few publications focused on the 
incorporation mechanisms into hair were published; however the mechanism is not yet 
completely clear. 
External hair contamination is closely related to this aspect. In fact any molecule that can be 
incorporated into the body by inhalation (vapour inhalation or smoking) needs to be considered 
as a possible source of contamination. This phenomenon can lead to positive results in hair 
analysis through passive transfer the hair shaft. 
In the same way any other substance, solid or liquid, which is handled by an individual could be 
transferred into the hair. So a proper decontamination of hair is required in order to avoid false 
positives due to passive environmental exposure (Boumba et al. 2006). 
A way to discriminate between external contamination and endogenous content relies on the 
assessment of metabolites: this aspect can represent a distinct advantage of drug analysis in hair, 




3.1.3 Hair preparation and decontamination 
 
Some precautions need to be taken during the human hair sampling. Sample weight usually 
ranges from 100 to 200 mg of hair, moreover the cut must be taken from the occipital region of 
the head and as close to the scalp as possible in order to obtain the most suitable sample to 
identifying the selected analytes. Hair samples should be stored in a dry place, under dark 
conditions, at room temperature in aluminum foil, polyethylene bags or envelope (Boumba et al. 
2006; Schramm 2008). 
However some studies advise against storage in plastic bags because of possible contamination 
by softeners, such as plasticizers and because plastic can potentially take out lipophilic molecules 
from hair. Moreover only metal or quartz scissors should be used in order to not contaminate 
samples with the substance to be examined (Schramm 2008).  
In this way most drugs or metabolites in hair are stable and can be detected after years of storage 
(Pragst & Balikova 2006).  
Preparation for analysis is another step that follows hair collection.  
As already discussed above, washing hair sample from external contamination is needed for two 
reasons:  
 
1. to eliminate residue of hair care products such as shampoo, hair sprays, as well as sweat, 
sebum and dust that can lead to increased analytical background;  
 
2. drugs could come from the environment of the individual, potentially leading to 
incorrect test results. Thus in order to exclude that a positive analytical result can 
originate from this type of external contamination, the first wash solution should be 
checked for subsequent analysis (Pragst & Balikova 2006). 
 
Schramm et al. (1992) confirmed that washing step removes fat and sweat as well as exogenous 
substances from the surface of hair (Schramm 2008). 
In general three types of solvents are used for washing external contaminants: solutions of 
surfactants in water such as 0.1-5% solution of sodium dodecyl sulphate, hydrophilic organic 
solvents and hydrophobic organic solvents. Moreover several types of cleaning solvents can be 
used, but also taking account that they should not damage the hair matrix (Pragst & Balikova 
2006; Schramm 2008). 
The importance of an effective method to differentiate between endogenous and external 
 34 
contamination is obvious. The simplest way would be a cleansing protocol that would eliminate 
the contamination and leave the endogenously incorporated molecules (Kempson & Lombi 
2011).  
After the washing step hair is commonly dried in air or by a gentle flow of nitrogen.  
Then size reduction is executed after the washing step and according to Zhang et al. the powder-
like state of the sample will enhance the efficiency of subsequent extraction (Zhang et al. 2007).  
Furthermore all compounds of interest should be extracted by solubilization (supercritical fluid 
extraction and liquid extraction), or with liquid-liquid extraction (LLE), solid-phase extraction 
(SPE), solid-phase micro-extraction (Schramm 2008). 
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3.1.4 Hair biomonitoring 
 
Human hair is a durable matrix that shows various benefits for human biomonitoring, such as 
low cost, easy collection, non-invasive, easy storage and information about short and long-term 
exposure (Schramm 2008; Esteban & Castaño 2009). 
Biomonitoring, which is the contraction of ―biological monitoring‖ is considered as the 
assessment of human exposure to chemicals by directly measuring the molecules, their 
metabolites in biological matrices (Appenzeller & Tsatsakis 2012). 
Hair is a unique matrix, differing from other human biological samples used for toxicological 
analysis, such as blood or urine because it possesses a longer detection window, from months to 
years, that enables retrospective investigation of past substances assumed.  
Thus, because of its stability, hair analysis can be performed even centuries after growth (Pragst 
& Balikova 2006). Biomonitoring studies can provide lots of information, but also have some 
limitations: for example some molecules that are excreted quickly and therefore can be 
monitored for a short detection window after exposure.  
However hair analysis cannot identify the sources of chemical contaminants that were detected. 
In fact hair analysis cannot discriminate between substances that have directly deposited onto 
hair from those coming from other route of exposure, such as ingestion of contaminated 
drinking water. In other words, hair analysis generally can not differentiate internal from external 
exposure (Pickle et al. 1995; Needham et al. 2002; Esteban & Castaño 2009). 
Another factor to be considered is sensitivity that is particularly important in the case of hair 
analysis: the sample used is often limited to 50-200 mg compared to other matrices such as 
blood, serum, urine, in which the amount used for the determination of contaminants is usually 
2-5 mL (Appenzeller & Tsatsakis 2012). 
Even though hair has been used as a matrix since the 1950s to determine metals and since the 
1970s to measure drugs, its later use for analysis to investigate environmental exposure was due 
to lack of reliable and sensitive analytical methods. The relevant analytical advances during the 
past years have allowed scientists to reach adequate sensitivity levels (Appenzeller 2015). 
 
 
3.1.5 Bovine hair analysis 
 
Farm animals can be treated with veterinary drugs in order to control and prevent a broad range 
of diseases. The illegal or improper use of these substances as growth promoters may results in 
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the presence of drug residues in food products derived from these animals.  
The Council Regulation (EC) 2377/90 (today repealed) required that all veterinary drugs needed 
to be assessed: this regulation illustrated the procedure for the establishment, and in case of 
need, of the maximum residue limit (MRL) of a molecule in a certain matrix.  
Currently MRLs are established according to the procedures laid down in Regulation (EC) 
470/2009. Pharmacologically active substances and their classification regarding maximum 
residue limits are set out in Commission Regulation (EU) No 37/2010.  
Furthermore the use of any drug as a growth promoter is banned within the European Union by 
the Council Directive 96/22/EC which was amended by Directive 2003/74/EC (Commission 
of the European Communities 1996a; Council Directive 2003). In order to establish a high level 
of consumer safety, European Union 
Countries must implement residue monitoring plans to detect the illegal use or misuse of 
authorised veterinary medicines and the presence of environmental contaminants in food 
producing animals. The surveillance program, responsible to monitor the presence of residues of 
veterinary agents in food-producing animals and related products, is established by the Council 
Directive 96/23/EC and Commission Decision 2002/657/EC.  
This document specifies the guidelines for sampling procedures on both farms and 
slaughterhouses, setting the procedures and criteria to validate analytical methods common 
criteria for the interpretation of test results (Commission of the European Communities 1996b; 
European Commission 2002). The proper application of these surveillance programs requires the 
development of sensitive and robust analytical methods in order to guarantee the control from 
authorities with effective tools (Gratacós-Cubarsí et al. 2006). 
Veterinary drug residues are usually detected in urine and plasma matrices derived from living 
animals and also in tissue samples after slaughter such as muscle, kidney and liver.  
Veterinary drugs are generally characterised by high clearance rates in these biological matrices, 
making the retroactive detection of banned substances really difficult. In the past years various 
publications investigated if hair analysis could be considered a suitable matrix to control this 
problem in food producing animals. As previously described hair has been considered as a 
reliable matrix for the detection of various organic drugs, since the publication by Goldblum in 
1954 about amphetamine detection in hair of Guinea pigs (Gratacós-Cubarsí et al. 2006). 
In recent years some authors described the possible applications of hair analysis in the field of 
fraudulent detection of beta-agonists and anabolics in animals (Sauer & Anderson 1994). 
However publications on veterinary hair analysis are still few and tend to focus only on a limited 
number of substances, although hair could represent a promising matrix.  
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The understanding of veterinary drug deposition is still not adequate and the influence of 
veterinary drugs uptake in the hair of livestock productions is not fully investigated (Gratacós-
Cubarsí et al. 2006). 
 
 
3.1.6 Zearalenone biotransformation and exposure 
 
Zearalenone (ZEA) belongs to Fusarium mycotoxins and it is characterised by a ring system of a 
macrocyclic beta-resorcylic acid lactone (RAL). The given name of this compound comes from 
the its common occurrence in Zea mays, a mouldy maize, followed by the element RAL, and the 
alkene double bond (‗en‘) and keto group (‗one‘) of this substance (EFSA 2016). 
Many species of the genus Fusarium frequently infest cereals, in particular maize and other plant 
products all over the world (Maragos 2010). This mechanism allows ZEA to enter into the food 
chain of both animals and humans, that can be affected by adverse health risks. In livestock 
animals such as pig, cattle, and sheep, ZEA can cause reproductive and infertility disorders. 
In humans ZEA can cause hyperestrogenic siyndromes: this fact can be explained by the 
oestrogenic effect exerted by this compound. Thus zearalenone is an oestrogen analogue which 
is able to mimic the activity of naturally oestrogens (de Andrés et al. 2008). 
Zearalenone presence in food and feed is regulated in various countries of the world. The 
European Food Safety Authority (EFSA) has established a TDI of 0.25 g/kg body weight (bw), 
while the Joint Expert Committee on Food Additives (JECFA) set a provisional maximum 
tolerable daily intake (TDI) for ZEA of 0.5 g /kg (bw) (JECFA, 2000; EFSA 2011). 
Besides zearalenone and also its metabolites such as zeranol (ZAL) are considered oestrogen 
agonists in mammals, and they can occur in food such as cereal crops, fruits, vegetables.  
The use of zeranol (ZAL) is permitted as a growth promoter in beef in the USA and Canada 
(Mukherjee et al. 2014). 
These hormones can be produced naturally in the animal body, but they can also be artificially 
synthesized and added.  
In United States about 30 growth promoters are currently used, such as estradiol, progesterone, 
testosterone, zeranol, diethylstilbestrol (DES), in order to increase feed-to-meat conversion in 
livestock production. Zeranol (ZAL) is also used as a growth-promoter in other countries, 
including Australia, New Zealand, Canada, Mexico, Chile, Japan, South Africa (Johnson 2015). 
ZEA, ZAL and their metabolites were involved in precocious puberty cases in young girls of 
various countries, such as Italy in 1979, and Puerto Rico in the 1980s. 
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Other health effects associated with dietary exposure to ZAL residues in beef are not yet fully 
investigates (Mukherjee et al. 2014). 
Zeranol together with DES have been banned as meat additives in the European Union (EU): 
this fact leads to a EU ban about the import of meat products from the US and Canada. 
The Joint FAO/WHO Expert Committee on Food Additives (JECFA) set the Allowable Daily 
Intake (ADI) of ZAL in humans at 0.5 mg/kg body weight, which corresponds to a 35 mg 
allowable daily intake in a 70 kg adult. Furthermore the use of ZAL has been banned in sports by 
the International Olympic Committee and World Anti-Doping Agency, because of its anabolic 
effects (Haiyang et al. 2014; Mukherjee et al. 2014). 
Alpha-zearalanol (-ZAL) (Figure 5), known as zeranol, is a fungal metabolite produced from 
zearalenone (ZEA): -ZAL can also occur naturally in some foods, thus its presence in animal 
products can be partly explained by its ingestion in feed: it can be produced endogenously in 
ruminants fed by contaminated lots with zearalenone and derivatives (Erasmuson et al. 1994; 
D‘Mello et al. 1999; Zöllner et al. 2002; Zinedine et al. 2007). 
Fusarium isolates from grazings in New Zealand produced zearalenone and also metabolites 
alpha-zearalenol (-ZEL), beta-zearalenol (-ZEL), alpha-zearalanol (-ZAL), beta-zearalanol 
(-ZAL) and possibly also zearalanone (ZAN). Also in in vivo studies it was not possible 
determine if the source of the alpha-zearalanol in the urine was extrinsic, due to its present in the 
fodder, or if it was generated by the animal, through the metabolism of ingested mycotoxins 
present in the pasture (Erasmuson et al. 1994). 
Studies reveals zeranol can naturally be present in the bile of cattle following ingestion of 
Fusarium spp. toxins. Data showed that natural zeranol (-ZAL) can derive in major part from a-
zearalenol (-ZEL), a molecule separated from zeranol by only one metabolic step (Kennedy et 
al. 1998). 
Humans can be exposed to both ZEA and -ZAL through consumption of contaminated grains 
although there were reported cases of inhalation exposure in farm workers.  
However the most relevant exposure route for -ZAL can comes from treated meat (Mukherjee 
et al. 2014).  
The first study of ZEA in vivo metabolism was performed by Kiessling and Pettersson, who 
studied the livers of rats exposed to ZEA, indentifying two important steps: the reduction phase 
of zearalenone ketone group to zearalenol (ZEL), and the conjugation by glucuronic acid which 
leads to glucuronide form (Kiessling & Pettersson 1978; Mukherjee et al. 2014).  
However the biotransformation of these molecules, especially the conversion rates to different 
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metabolites can vary widely across species. Furthermore the extents and rates of different 
metabolic reactions are essential because the metabolites of ZEA differ in their estrogenic 
potential. The oestrogenicity of these compounds follows this order: -ZAL, -ZEL, -ZAL, 




The ketone group in ZEA or ZAN is reduced by aliphatic hydroxylation in order to form the 
corresponding alcohol. ZEA is converted to -, -zearalenol (-ZEL, -ZEL) (Figure 7) as 
catalysed by 3 - and 3 -hydroxy steroid dehydrogenase (HSD). Studies revealed a relevant 
variance of the reaction rates among species (Malekinejad et al. 2006; Pfeiffer et al. 2009).  
Thus rats seem to produce more -ZEL, while humans and pigs seem to show a preference 
towards -ZEL. Estrogenic effects can vary in each species, due to interspecies differences in 




In this phase of metabolism occur the glucuronidation and sulfation of the parent compounds or 
the phase I metabolites occur. The glucuronic acid group is provided by uridine 5‘-diphosphate 
glucuronic acid (UDPGA) and the conversion is performed by uridine 5‘-diphosphate 




In humans zeranol is mostly excreted by urine, whereas in other species, such as rats, fecal 
elimination represents the major route of elimination (Baldwin et al. 1983). 
Studies reveal zearalanone (ZAN) is a major metabolite of zeranol in humans, while -ZAL 
constitutes a minor one. Interestingly mammals dosed with -ZAL showed no traces of ZEA or 
- or -ZEL: this fact indicates that -ZAL and -ZAL can hold a reversible relation with 
ZAN; but zearanols are not converted to their unsaturated forms in mammals. 
In addition a peculiarity of ZAL human metabolism is that both ZAL and ZEA are metabolised 
to some extent in the intestine (Schaut et al. 2008; Mukherjee et al. 2014). 
In cattle -ZAL is metabolised into -ZAL and ZAN and are excreted in urine; the presence of 
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-ZAL and its metabolites in urine is used as a marker to detect the illegal use of ZAL (Haiyang 
et al. 2014). 
Other studies were performed in pigs and heifers: -ZAL and -ZAL were detected in the urine 
of animals fed ZEA contaminated cereals. According to these facts it can be suggested that in 
mammals the reduction of -ZEL, -ZEL and of ZEA to ZALs and ZAN can negligibly occur, 




Figure 7. Compounds of the zeranol family of mycotoxins and their biotransformation pathways. 




3.1.7 Analytical challenges and current state-of-the-art literature 
 
As previously described the European Union banned the use of many natural and synthetic 
hormones including -ZAL and -ZAL in livestock animals since 1985, therefore no residue of 
these compounds should be detected in samples of animal origin (Commission of the European 
Communities 1996a). On the other hand both these molecules can be naturally present in the 
urine from various animal species which were fed by contamined ZEA lots. 
Highly sensitive and specific confirmatory methods capable of achieving very low detection 
levels are needed in order to identify the residues of resorcylic acid lactones (A4 group) in 
biological matrices of animal origin (Matraszek-Zuchowska et al. 2013).  
However there are still many concerns about how to discriminate between ZEA environmental 
contamination and -ZAL abuse: a possible method can rely on testing samples for both for -
ZAL, its metabolites β-ZAL and ZAN, as well as for the presence of ZEA and its metabolites α- 
and β-ZEL (Launay et al. 2004; Blokland et al. 2006). 
Moreover -ZAL and ZEA can give identical metabolites, which justifies why these metabolites, 
including -ZAL itself, can also be detected in ovine urine and bovine bile after Fusarium spp. 
toxin biotransformation. 
To discriminate forbidden treatment of zeranol from ingestion of contaminated feed with 
Fusarium spp. toxin, it was suggested that analysis for ZAL abuse would imply quantification of 
zeranol and its metabolites β-ZAL and of ZEA and its two major metabolites α-ZEL and β-
ZEL (Blokland et al. 2006). 
The model may help laboratories involved in a ZAL testing, in order to distinguish between 
illegal use of zeranol and natural contamination. The main principle is based on the comparison 
of the sum of the -ZAL and β-ZAL concentrations with the sum for ZEA and its metabolites, 
α-ZEL and β-ZEL (Blokland et al. 2006). 
For many years the detection of RALs was performed by thin layer chromatography (TLC), 
enzyme-linked immunosorbent assay (ELISA), radioimmunoassay (RIA), HPLC and 
fluoroimmunoassay (FIA). These analytical methods are not enough sensitive or specific.  
A factor to take into account is that with ELISA and RIA methods it is not possible to detect -
ZAL metabolites and other molecules from RALs simultaneously in only one analysis. 
Chromatographic methods play a relevant role in the residue analysis of anabolic substances 
both for screening and for confirmatory analysis (Stolker & Brinkman 2005). Most of the 
published confirmatory analysis for α-ZAL and its metabolites in biological matrices is based on 
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GC/MS: a complex and usually time-consuming method because of derivatisation step (Seo et 
al. 2005; Blokland et al. 2006). Recently LC coupled with MS or MS/MS also been used for the 
determination of -ZAL in animal matrices displaying benefits in terms of sensitivity and 
specificity (Launay et al. 2004; Matraszek-Zuchowska et al. 2013). 
According to EFSA, the results from the European National Residue Control Programmes 2005 
- 2010 displayed a ―high incidence‖ of bovine samples non-compliant for -ZAL; specifically 
221 non-compliant samples out of 73626 total samples tested for RALs. Data reveals that the 
source of the low levels of zeranol and its metabolites detected in these samples may derive from 
cattle exposure to zearalenone in their diet. However taking account the non-compliant results 
that have been detected in most years of National Residue Control Programmes testing, which 
have been ascribed largely to dietary exposure, these molecules can represent a potential concern. 
Thus it is desirable that monitoring measures for RALs might converge on determining illegal 
use of these substances in bovine production in the EU (EFSA BIOHAZ Panel 2013). 
According to Choi et al. blood is the most common matrix in human biomonitoring studies 
(67%), followed by urine (57%) and hair (35%) (Choi et al. 2015). 
A review paper from Appenzeller and Tsatsakis (2012) analysed various research works that 
described the possibility of identyfing different contaminants in hair, reflecting environmental or 
occupational exposure (Appenzeller & Tsatsakis 2012). Many papers used hair to monitor and 
determine different organic pollutants, such as workplace exposure to pesticides, dioxins, 
polycyclic aromatic hydrocarbons (PAHs) have been determined in hair (Covaci et al. 2002; 
Toriba et al. 2003; Nakao et al. 2005; Chan et al. 2007). There are also studies on perfluoroalkyl 
compounds, brominated flame retardants, plastic additives such as bisphenol A and parabens 
(Martín et al. 2015; Wang et al. 2017; Qiao et al. 2018). 
Studies about human biomarkers related to mycotoxins began in the early 1990‘s to offer an 
overview into about mechanisms of action of aflatoxin B1. 
Moreover aflatoxin M1 was considered a biomarker of exposure, determined in milk and urine 
during exposure assessments (Gambacorta et al. 2013). Changes in the sphingosine/sphinganine 
ratio were also used for biomonitoring fumonisins studies in humans (Gilbert et al. 2001; 
Shephard et al. 2007). 
In recent years a large number of mycotoxins and its metabolites have been detected in various 
biological samples, such as urine and serum; some studies determined these contaminants on less 
common biological fluids such as breast milk, bile, saliva, nasal secretions, amniotic fluids 
(Escrivá et al. 2017). 
Also the type of animal species in biomonitoring studies in serum are 50% from human 
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provenance, followed by pig (17%), chicken (13%), rat (9%) and in minor proportion fish, hens, 
horse. 
Studies focusing on mycotoxin urine analysis were performed on human (80%), to a lower extent 
from pig (9%), bovine (6%), cattle (3%) and rat (2%) (Escrivá et al. 2017). 
Sewram et al. (2001) showed for the first time in 2001 and 2003 that FB1, FB2 and FB3 can 
accumulate respectively in monkey/rat and human hair, as a result of contaminated feed and 
maize consumption (Sewram et al. 2001; Sewram et al. 2003). 
To date there are few papers investigating the presence of mycotoxin in hair: Carrasquillas et al. 
determined for the first time anabolic compounds such as alpha and beta zearalanol in bovine 
hair using GC-MS (Hernández-Carrasquilla 2001). 
Bordin et al. (2015) identified FB1 levels in human hair from volunteers in Brazil and found low 
concentrations associated with FB1 daily intake values (Bordin et al. 2015). 
More recently Souto et al. (2017) determined fumonisin B1 presence in plasma, urine, feces and 





3.2 MATERIALS  AND  METHODS 
 
 
The present work was conducted to develop a method for quantitative determination of 
mycotoxin zearalenone and its metabolites (α-zearalenol, β-zearalenol, α-zearalanol, β-zearalanol 
and zearalanone) in bovine and human hair using LC-MS/MS. 
This work was funded by the Dutch Ministry of Agriculture (WOT-02-003-070). 
 
3.2.1 List of abbreviations 
 
ACN   Acetonitrile 
HCOOH Formic acid 
H2O  Water 
IAC  Immunoaffinity column 
ISS  Internal standard solution 
MeOH  Methanol 
MMRS  Matrix Matched Recovery Standards 
MMS  Matrix Matched Standards 
MSS  Mix solution standards 
PBS  Phosphate buffered saline 





Twenty four samples from both bovine and calf hair from The Netherlands, were chosen to 
perform a three day validation plan (Table 4). Red, brown, black, white, red and white, brown 
and white, black and white hair samples were collected. Samples were stored in plastic trays in 





































B Bovine 408651 
C Bovine 408652 
D Bovine 408653 
E Bovine 408658 
F Bovine 408659 
G Bovine 408661 
H Bovine 408697 
I Calf 3 
J Calf 7 
K Calf 8 
L Calf 9 
M Calf 11 
N Calf 53 
O Calf 76 
P Calf 77 
Q Calf 6 
R Calf 26 
S Calf 27 
T Calf 39 
U Calf 50 
V Calf 67 
W Calf 75 
X Calf 87 
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3.2.3 Glassware and consumables 
 
 Several pipets; 
 Polypropylene (PP) tube 12 mL with screw cap (Greiner 163275); 
 12 mL glass tube (Beldico, 8739007); 
 10 mL glass tube with screw cap (16 x 100 mm Kimble/Kimax USA 45066A-16100); 
 Polypropylene tube 50 mL with screwcap (Greiner 210261); 
 Glass 2 mL HPLC vial (Waters 186000327c); 
 IAC easi-extract zearalenone (R-Biopharm Rhône LTD RP90); 
 
 
3.2.4 Lab Equipment 
 
 Analytical balance with trueness of 0.02 mg (Mettler AT 261, Marshall Scientific); 
 Balance with trueness of 1 mg or better (Mettler PG503-S, Marshall Scientific); 
 Laboratory centrifuge (MSE Falcon 6/300); 
 Evaporation device (Turbo-Vap LV Zymark 44467); 
 Vortex mixer (iKA Vibrofix VF1); 
 Milli-Q system with a resistivity of at least 18.2 M Ωcm−1 (Merck Millipore); 
 Ultrasonic bath (Elma, Elmasonic S100); 
 MM400 ball mill (Retsch, Germany) equipped with: 
 2 buckets coated from the inside with zirconium oxide, 
  5 zirconium oxide balls (d=10 mm). 
 SPE system (Alltech) with vacuum pump (KNF Lab Laboport UN 842.3FTP); 
 LC-MS/MS system consisting of Waters Acquity pump and injection system. Analytical 
column: Acquity UPLC CSH 2.1 x 100 mm x 1.7 µm (Waters 186005297).  









 α-zearalanol (NMI Australian Government P 1801); 
 ß-zearalanol (NMI Australian Government P 1802); 
 α-zearalenol (Sigma-Aldrich, St Louis MO, USA, Z0166);  
 ß-zearalenol (Sigma-Aldrich, St Louis MO, USA, Z 2000); 
 Zearalanone (LGC Standards B-MYC 0580-1); 
 Zearalenone (Sigma-Aldrich, St Louis MO, USA,  Z-2125); 
 α/ß-zearalanol-d4 (RIKILT EU/CRL 006): this is an ampul containing 0.05 mg  
α-zearalanol-d4 and 0.05 mg ß-zearalanol-d4; 
 α-zearalenol-d4 (RIKILT EU/CRL 048): this is an ampul containing 0.1 mg  
α-zearalenol-d4; 
 ß-zearalenol-d4 (RIKILT EU/CRL 049): this is an ampul containing 0.1 mg  
ß-zearalenol-d4; 
 Zearalanone-d6 (TRC Z270442) this is a vial containing 0.5 mg standard; 





 Acetonitrile (Biosolve 01203502); 
 Ammonium formate 97% (Sigma-Aldrich, St Louis MO, USA, 15.626-4); 
 Methanol (Biosolve 13683502); 





 Stock standard solutions 1000 mg/L: each standard was prepared by dissolving 
accurately (between 1 and 5 mg ± 0.02 mg) in MeOH. Stock solutions were stored in a 
freezer for two years period of storage. 
 48 
 MSS I 10 mg/L: 100 µL of each standard stock solution were pipetted into a volumetric 
flask of 10 mL and made up to volume with MeOH. This solution was stored in a 
refrigerator for six months period of storage. 
 
 MSS II 0.1 mg/L: 100 µL of MMS I were pipetted into a volumetric flask of 10 mL and 
made up to volume with MeOH. This solution was stored in a refrigerator for one 
month period of storage. 
 
 MSS III 0.01 mg/L: 1000 µL of MMS II were pipetted into a volumetric flask of 10 mL 
and made up to volume with MeOH. This solution was stored in a refrigerator for one 
month period of storage. 
 
 Stock solution internal standard I 10 mg/L: 1 mL MeOH was added to each ampoule, 
placed subsequently in an ultrasonic bath for one minute. Thus it was mixed and 
transferred in a 5 mL and 10 mL flasks. The content was filled up with MeOH and 
mixed. The stock solutions were stored in a freezer for five years period of storage. 
 
 Stock solutions internal standard II 1000 mg/L: 0.5 mL MeOH was pipetted in a vial 
containing zearalanone-d6 internal standard and 1.0 mL MeOH was pipetted in a vial 
containing zearalenone-d6 internal standard. These solutions were mixed, vortexed and 
stored in a freezer for five years period of storage. 
 
 ISS I 10 mg/L: 100 µL of each internal standard stock solution 1000 mg/L was pipetted 
in a 10 mL volumetric flask and made up to volume with MeOH. This solution was 
stored in refrigerator for six months period of storage. 
 
 ISS II 0.1 mg/L: 100 µL of each internal standard stock solution ISS 10 mg/L were 
pipetted and put into a volumetric flask of 10 mL, made up to volume with MeOH.    
This solution was stored in refrigerator for one month period of storage. 
 
 Working standard solution 1.7 µg/L: 40 µL MMS III and 20 µL ISS II were pipetted in a 




 All solvents used for mass spectrometry analysis were LC-MS grade. 
 Solvents employed during sample preparation were all analytical grade. 
 Milli-Q water, referred to as water from here on. 
 
 
Prepared solutions  
 
 MeOH/water 40/60 v/v:  400 mL MeOH were mixed in 600 mL of water. This solution 
was stored at room temperature for three months period of storage. 
 
 Ammonium formate 1 M LC-MS grade: 6.3 gram of ammoniumformate were dissolved 
in 100 mL of water. This solution was stored at room temperature for three months 
period of storage. 
 
 ACN/water 90/10 (v/v) LC-MS grade: 900 mL ACN were mixed with 100 mL of water. 
This solution was stored at room temperature for three months period of storage. 
 
 PBS solution: the content of the packet was dissolved in 1 L of water. This solution (pH 
7.4) contained 0.01 M phosphate buffer, 0.138 M NaCl and 0.0027 M KCl. 
 
 Mobile phase A: Ammonium formate (1M)/HCOOH/water 2/0.5/1000 (v/v/v): 2 mL 
of ammoniumformate (1M) were mixed with 0.5 mL of HCOOH and 1000 mL of water 
LC-MS grade. This solution was stored at room temperature for one month period of 
storage.  
 
 Mobile phase B: Ammonium formate (1M)/HCOOH/ACN/water 2/0.5/900/100 
(v/v/v/v): 2 mL ammoniumformate (1M) were mixed with 0.5 mL HCOOH and 1000 
mL ACN/water 90/10 LC-MS grade. This solution was stored at room temperature one 
month period of storage. 
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3.2.6 Sample preparation and sample series 
 
 Sample pretreatment  
 
A bucket, equipped with 5 balls, was filled with about 500 mg hair. The content was 
pulverised for 4 minutes at 25 Hz, subsequently pulverised hair were transferred in a 12 
mL polypropylene (PP) tube. 
 
 Sample series composition for each validation day 
 
 6 blank hair samples which were spiked before processing (MMS), according to  
table 5; 
 blank samples which were included in each series; 
 hair samples; 
 MMRS sample obtained from blank hair sample which was spiked with matrix 
standard solution only after processing, according to table 5; 
 working standard solution. 
 
 MMS, MMRS preparation  
 
Calibration was performed using MMS samples, while recovery rate was obtained using 
MMRS sample. Hair samples were weighed and put in polypropylene tubes (12 mL); 
subsequently samples were spiked with standard solution (normal standard and internal 
one), according to table 5. Then spiked samples were mixed with vortex and were let 





Table 5. Scheme preparation of matrix matched standards (MMS) and 
 matrix matched recovery standard (MMRS) used for each validation day. 
 
 
 Sample preparation 
 
200 mg of samples were weighed and put in polypropylene tubes (12 mL), subsequently 
10 µL ISS I (0.1 mg/l) were added to each sample. Finally they were mixed with vortex 




2 mL MeOH were added to each hair samples and then they were vortexed.  
Samples tubes were placed in ultrasonic bath for one hour, subsequently they were 
centrifuged for 5 min at 3600 G in order to obtain the upper layer, which was transferred 
in a new 50 mL polypropylene tube. Finally 11 mL PBS solution were added and mixed. 
 
 Sample clean-up IAC 
 
IAC columns were placed onto a SPE unit: these columns were first conditioned with 
the filling solution being present at each IAC and then with 3 mL PBS solution.  
Matrix Matched 
Standards 
µL MSS III 
(0.01 mg/L) 
µL MSS II 
(0.1 mg/L) 
µL ISS I 
(0.1 mg/L) 
MMS A (0 µg/kg)   10 
MMS B (0.25 µg/kg) 5  10 
MMS C (0.5 µg/kg) 10  10 
MMS D (1.0 µg/kg) 20  10 
MMS E (2.0 µg/kg) 40  10 
MMS G (5.0 µg/kg)  10 10 
MMRS A (1.0 µg/kg) 20  10 
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Hair samples were loaded on to the columns and drained through the columns under 
gravity, at a speed of one drop per second. Then the columns were washed with 10 mL 
PBS solution followed by 10 mL of water to remove any impurities. Subsequently a 
gentle vacuum was applied for a few seconds and finally the valve was closed. All the 
solutions, which passed through the column until this step, were discarded. 
Elution of target analytes was started with the addition of 2 mL ACN, before being 
stopped for 15 min after collecting the first 4-5 drops. Sufficient contact time with ACN 
was necessary to promote the unbinding between analytes and antibodies. After 15 
minutes the eluition was restarted collecting the remaining volume of ACN by gravity. 
The eluate was evaporated to dryness at 55 °C under a gentle stream of nitrogen.  
Subsequently the residue was reconstituted in 120 µL MeOH/water 40/60 and vortexed 
for few seconds. The final extract was transferred into a 2 mL conical vial for injection 
into the LC-MS/MS system. 




















Figure 8. Sample extraction/clean-up scheme.  
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3.2.7 Analytical conditions 
 
 LC conditions 
 
Analytical column: Acquity UPLC CSH C18 2.1 * 100 mm* 1.7 µm  
Column temperature: 50°C 
Vial tray temperature: 10°C 
Flow:   0.5 mL/min 
Injection volume: 10 µL 
Gradient:  see table 6 

















Time (min) Mobile phase A (%) Mobile phase B (%) 
0 80 20 
2 50 50 
6 30 70 
7 0 100 
8 0 100 
9 80 20 
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 MS conditions 
 




































Ionisation mode ESI negative 
Capillary voltage 2.5 kV 
Cone Component depends V 




Desolvation gas flow 800 L/hour 
Cone gas flow 150 L/hour 
Multiplier 750 
Nebuliser gas flow (bar) 7 
LM 1 resolution 3.0 
HM 1 resolution 15.0 
Ion energy 1 1.9 
LM 2 resolution 3.0 
HM 2 resolution 15.0 
Ion energy 2 1.3 
CID gas 
Argon, p = 2.5 x 10-3 mbar   
purity > 99.998% 




Table 8. Guidelines MS/MS fragmentation. Theoretical mono-isotopic masses of the precursor ions 





Compounds Precursor Product Cone (V) CE (eV) IS 
zearalenone 317.15 
131.15 44 30 zearalenone-d6 
175.15 44 24  
zearalanone 319.15 
275.15 30 21 zearalanon-d6 
205.15 30 22  
α/ß-zearalenol 319.15 
160.15 30 30 α/ß-zearalenol-d4 
275.15 30 21  
α/ß-zearalanol 321.15 
277.15 56 20 α/ß-zearalanol-d4 
259.15 56 26  
α/ß-zearalenol-d4 323.15 160.15 45 32  
α/ß-zearalanol-d4 325.15 281.15 50 20  
zearalanon-d6 325.15 281.15 50 20  
zearalenone-d6 323.15 175.15 50 23  
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3.2.8 Method validation in bovine hair 
 
 Bovine validation scheme 
 










Day 1 Validation Day 2 Validation Day 3 Validation * 






         
MMS 1 0 A Blanco_2005M0718 I Calve3 Q Calve6 
MMS 2 0.25 A Blanco_2005M0718 I Calve3 Q Calve6 
MMS 3 0.5 A Blanco_2005M0718 I Calve3 Q Calve6 
MMS 4 1 A Blanco_2005M0718 I Calve3 Q Calve6 
MMS 5 2 A Blanco_2005M0718 I Calve3 Q Calve6 
MMS 6 5 A Blanco_2005M0718 I Calve3 Q Calve6 
         
MMRS 7 1 A Blanco_2005M0718 I Calve3 Q Calve6 
MMRS 8 1 I RIK_408668 - - - - 
MMRS 9 1 Q RIK_408698 - - - - 
         
Sample 10 0 B RIK_408651 J Calve7 R Calve26 
Sample 11 0 C RIK_408652 K Calve8 S Calve27 
Sample 12 0 D RIK_408653 L Calve9 T Calve39 
Sample 13 0 E RIK_408658 M Calve11 U Calve50 
Sample 14 0 F RIK_408659 N Calve53 V Calve67 
Sample 15 0 G RIK_408661 O Calve76 W Calve75 
Sample 16 0 H RIK_408697 P Calve77 X Calve87 
         
Sample 17 0.5 B RIK_408651 J Calve7 R Calve26 
Sample 18 0.5 C RIK_408652 K Calve8 S Calve27 
Sample 19 0.5 D RIK_408653 L Calve9 T Calve39 
Sample 20 0.5 E RIK_408658 M Calve11 U Calve50 
Sample 21 0.5 F RIK_408659 N Calve53 V Calve67 
Sample 22 0.5 G RIK_408661 O Calve76 W Calve75 




Table 9. Validation scheme for three validation days.  
* Six samples used for robustness were not reported. 
  




Day 1 Validation Day 2 Validation Day 3 Validation * 
Letter ID Number Letter ID Number Letter Letter 
         
Sample  24 1 B RIK_408652 J Calve7 R Calve26 
Sample 25 1 C RIK_408652 K Calve8 S Calve27 
Sample 26 1 D RIK_408653 L Calve9 T Calve39 
Sample 27 1 E RIK_408658 M Calve11 U Calve50 
Sample 28 1 F RIK_408659 N Calve53 V Calve67 
Sample 29 1 G RIK_408661 O Calve76 W Calve75 
Sample 30 1 H RIK_408697 P Calve77 X Calve87 
         
Sample 31 1.5 B RIK_408651 J Calve7 R Calve26 
Sample 32 1.5 C RIK_408652 K Calve8 S Calve27 
Sample 33 1.5 D RIK_408653 L Calve9 T Calve39 
Sample 34 1.5 E RIK_408658 M Calve11 U Calve50 
Sample 35 1.5 F RIK_408659 N Calve53 V Calve67 
Sample 36 1.5 G RIK_408661 O Calve76 W Calve75 
Sample 37 1.5 H RIK_408697 P Calve77 X Calve87 
         
Sample 38 1 B RIK_408651 J Calve7 Q Calve6 
Sample 39 1 B RIK_408651 J Calve7 Q Calve6 
Sample 40 1 B RIK_408651 J Calve7 Q Calve6 
Sample 41 1 B RIK_408651 J Calve7 Q Calve6 
Sample 42 1 B RIK_408651 J Calve7 Q Calve6 
Sample 43 1 B RIK_408651 J Calve7 Q Calve6 

















 Criteria for individual samples 
 
For each sample were calculated: 
 
 the response factor; 
  the relative deviation of the relative retention time; 
  the relative deviation of the ion ratio. 
 
Calculations used to obtain these parameters are specified below. 
 
 Calculations  
 





R = ion ratio (%) 
Alow  = area of the product ion with the lowest intensity 





























D = relative deviation of the ion ratio of the compound in the sample compared to 
the average ion ratio of the compound in MMS B to F before and after samples 
Rsample = ion ratio of the compound in the sample 
Raver. = average ion ratio of the compound in MMS B to F before and after samples 
 
 





RF = response factor 
Aanalyt = sum of the peak areas of the product ions 
AIS = area of the product ion of the of the internal standard 
 
 





X  = concentration in sample (µg/kg) 
RF  = response factor, see equation III 
b  = intercept of the calibration line of the MMS before and after the samples (linear 
regression*) 
a  = slope of the calibration line of the MMS before and after the samples (linear 
regression*) 
*They were applied least squares linear regression to the response factor and the 






























RRT  = relative retention time 
RTanalyte  = retention time of the compound 
RTIS         = retention time of the internal standard 
 
 





ΔRRT   = deviation of the relative retention time of the compound 
RRTsample = relative retention time of the compound, see equation V (%) 
RRTave  = average relative retention time of MMS B t/m F before and after  
samples see equation V (%) 
 
 





Amin  = Minimal area internal standard for securing detection at 0.25 µg/kg 
AMMS_RL = Area of the least intense product ion of MMS 0.25 µg/kg before the  
samples 





 Validation criteria 
 
Different samples were used each validation day (table 10): 
 one for linearity (e.g. sample A for day 1); 
 seven different ones for trueness, inter-day repeatability, within-lab 
reproducibility, selectivity, decision limit CCα, detection capability CCß (e.g. 
samlples B-H for day 1); 
  one sample for intra-day repeatability (e.g. sample B for day 1).  
 
Since no maximum residue limit (MRL) have been established for zearanols 











Table 10. Different parameters tested during the validation process. 
 
The following listed criteria were calculated based on the validation schemes during three 
validation days (table 10): 
 
 
 Linearity  
 
The linearity of the method was determined with the correlation of MMS 
calibration lines. The correlation of both lines should be ≥ 0.990. 
As reported in table 10, linearity was calculated analysing the same sample type 























1 7 (A) 7*3 (B-H) 7*(1xGV) B 7 (B-H)  1(l) 1(Q) 44 
2 7 (I) 7*3 (J-P) 7*(1xGV) J 7 (J-P)   42 




The recovery of the method was calculated analysing once the same sample used 




The S/N of the less intense product ion of MMS B (Table 10) should be ≥ 6. 
 
 Trueness (T) 
 
Trueness was obtained analysing seven samples spiked at 0.5 – 1.0 - 1.5 x GV 
(Table 11). 
According to 2002/657/EC this parameter at the selected validations levels should 
be between 50%-120%  at 0.5 – 1.0 x GV, 70%-120% at 1.5 x GV. 
 
 Within-laboratory reproducibility / Inter-day repeatability/ Intra-day 
repeatability) 
 
The first two parameters were calculated analysing seven samples spiked at 0.5 – 
1.0 - 1.5 x GV (Table 11), using single factor analysis of variance (ANOVA).  
Intra-day repeatability was obtained analysing in seven-fold the same sample spiked 
at 0.5 – 1.0 - 1.5 x GV (Table 11). 
The relative within-laboratory reproducibility (RSDRL) and the relative repeatability 
(RSDr) were calculated on the basis of Horwitz equation: these parameters have 
large values at low concentrations.  
Thompson et al. prescribed that at concentrations below 120 g/Kg, maximum 
RSDRL can be used as 22%. This criterion results in a maximum RSDr of 14.7% 












All compounds 1 
0.5 50-120 14.7 22.0 
1.0 50-120 14.7 22.0 
1.5 70-110 14.7 22.0 
   
   Table 11. Trueness (T), repeatability RSDr (%) and 
    within-laboratory reproducibility RSDRL (%) criteria. 
 
 CC / CC 
 
Seven different samples spiked at 0.5 – 1.0 - 1.5 x GV were used to calculate 
these parameters (e.g. B-H for validation day 1, see table 10). 
The detection capability CC was set at a spiking concentration at which 95% 
of the sample identity of analyte was confirmed. The decision limit (CC), 




Selectivity represents the discrimination between the analyte and closely 
related substances (e.g. isomers) or matrix interferents. Seven blank samples 
per each validation day (e.g. B-H for validation day 1, see Table 10) were 
tested: these samples were spiked with only internal standard and assessed for 
the presence or absence of a signal on the expected retention time. 
 
 Matrix effect 
 
Matrix effect was assessed by comparing the response of MMRS and standard 





In accordance with EC Decision 2002/657/EC the stability in solution and 
matrix must be determined. 
Stability of extracts has been determined through MMRS samples. If the 
decrease of an analyte is <15% the analyte in the sample extract was 
considered stable. MMRS stability was assessed after one and two weeks of 
storage in the freezer respectively.vThe stability of zeranols in sample extracts 
was further verified by storing  validation day 3 series in freezer. After one 





Robustness has been tested by applying three small changes in the method in 
duplicate. The robustness of the analysis was tested during method 
development and additionally during the validation. Three small deviations 
from the method were tested during the validation. This has not been carried 
out in accordance with the validation plan. Instead of three minor changes in 
duplicate, six minor changes were carried out and 0.5 μg/kg were tested 
instead of 1.0 μg/kg (table 12): 
 
 50 and 70 min ultrasonic bath instead of 60 minutes; 
 Centrifugation at 3000G and 4000G instead of 3600G; 









Table 12. Six minor changes for robustness test.  
Level  Procedure Change 
1 * GV  60 min ultrasonic bath 50-70 minutes ultrasonic bath 
1 * GV  60 min ultrasonic bath 50-70 minutes ultrasonic bath 
1 * GV  Centrifugation at 3600 G Centrifugation at 3000-4000 G 
1 * GV  Centrifugation at 3600 G Centrifugation at 3000-4000 G 
1 * GV  Evaporation at 550 C Evaporation 50°C-600 C 
1 * GV  Evaporation 550 C Evaporation 50°C-600 C 
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 Change in response factor 
 
MMS samples were run before and after the samples. 
 
 Maximum deviation relative retention time 
 
The average relative retention time of the MMS was calculated before and after the 
sample analysis. The deviation in the relative retention time of each MMS sample 
was compared to the average; the final result should not exceed 2.5%.  
 
 Maximum deviation ion ratio 
 
Average ion ratio of the MMS was calculated before and after the samples 
analysis.  
The deviation in the ion ratio of each MMS sample was compared to the average; 











Table 13. Maximum permitted tolerances for relative  
ion intensities according to EU criteria. 
 
  
Average ion ratio MMS 
(R) 
Permitted relative deviation 
(D) 
R > 50% 20% 
20% < R  50 % 25% 
10% < R  20 % 30% 
R  10% 50% 
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 Securing the detection 
 
To secure the reporting limit, every sample was checked by the signal of its 
internal standard. The minimal area of the internal standard in a sample was 
calculated where the reporting limit is secured using equation VII.  
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3.2.9 Method development in bovine hair 
 
Many preliminary experiments were performed to set-up the final protocol (see 3.2.6 and 3.2.7 
sections for the final protocol).  
 This first part will focus on extraction-clean-up trials investigating the best extraction and 
clean-up method: Experiment A, B, C, D; 
 The second part will focus on LC settings trials: Experiment E. 
 
3.2.9.1 Extraction/Clean-up set-up 
 




Same blank bovine hair sample was used. 
 
Glassware and consumables 
 
 Several pipets; 
 Polypropylene (PP) tube 12 mL with screw cap (Greiner 163275); 
 12 mL glass tube (Beldico, 8739007); 
 10 mL glass tube with screw cap (16 x 100 mm Kimble/Kimax USA 45066A-16100); 
 Polypropylene tube 50 mL with screwcap (Greiner 210261); 
 Glass 2 mL HPLC vial (Waters 186000327c); 
 SPE Bond Elut C18  (50 mg, 3 mL; Agilent, USA); 
 Bond Elut-NH2 (1g, 6 mL; Agilent, USA); 




See 3.2.4 section. 
  
 68 








 Acetonitrile (Biosolve 01203502); 
 MeOH (Biosolve 13683502); 
 Tris(2-carboxyethyl)phosphine hydrochloride (TCEP) (≥98%) (Sigma-Aldrich, St 
Louis MO, USA); 
 Acetone (Biosolve BV, The Netherlands); 
 Methyl- tert-butyl ether (MTBE) (Sigma-Aldrich, St Louis MO, USA). 
 
 Standard solutions 
 
 MSS I 0.01 mg/L: 1000 µL of mix standard solution were pipetted into a 
volumetric flask of 10 mL and made up to volume with MeOH. This solution 
was stored in a refrigerator for one month period of storage. 
 
 ISS I 0.1 mg/L: 100 µL of each  internal standard solution were pipetted into a 
volumetric flask of 10 mL and made up to volume with MeOH. This solution 




See 3.2.5 section. 
 
 Prepared solutions 
 
 MeOH/water 40/60 v/v: 40 mL MeOH were mixed in 60 mL of water. This 
solution was stored at room temperaturefor three months period of storage; 
 MeOH/water 80/20 v/v: 80 mL MeOH were mixed in 20 mL of water. This 
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solution was stored at room temperaturefor three months period of storage; 
 acetone/MeOH 80/20 v/v: 80 mL of acetone were mixed in 20 mL MeOH. This 





 Sample pretreatment, sample series composition 
 
See section 3.2.6. 
 
 MMS preparation 
 










Table 14. Spiking level of MMS and MMRS. 
 
 
 Sample preparation 
 










Blank Hair MMS 0 0 40 
Blank Hair MMS 0.25 5 40 
Blank Hair MMS 0.5 10 40 
Blank Hair MMS 1 20 40 
Blank Hair MMRS 1 20 40 
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 Extraction  
 
1. 200 mg of bovine hair were weighed accurately in 15 mL in polypropylene tube (PP), 
moreover MMS, MMRS, samples were spiked, as reported in table 12; 
2. 2 mL Tris(2-carboxyethyl)phosphine hydrochloride (TCEP) (7.25 mg/ml water) were 
added and vortexed for few seconds; 
3. PP tubes were put into head over head rotator (position 4) for one hour. 
Subsequently 4 ml MeOH HPLC grade were added; 
4. PP tubes were centrifugated for 5 minutes at 1700 G and the upper (organic) layer 
was transferred into a new PP tube, with the addition of 5 ml distilled water. 
 
 Sample clean-up 
 
This clean-up method was made on the basis of a previous modified protocol, set-up for the 
zearanols determination in urine, which is summarised below.  
 
5. SPE C18  cartridges were placed onto a SPE unit and conditioned with 5 mL MeOH 
followed by 5 mL of water; 
6. samples were loaded onto C18 SPE cartridges and washed with 5 ml MeOH/water 
40/60; 
7. SPE cartridges were dried before the next step by applying slight vacuum; 
8. eluition of target analytes were performed with 5 mL MeOH/water 80/20, then the 
eluate was collected in a glass tube and evaporated to dryness at 50°C under a gentle 
steam of nitrogen; 
9. the dry residue was reconstituted in 5 mL acetone/MeOH 80/20; 
10. meantime another SPE NH2  cartridges were conditioned with 5 mL of 
acetone/MeOH 80/20; 
11. samples, previously reconstituted in 5 mL acetone/MeOH 80/20; were loaded onto 
SPE NH2 cartridge, then the eluate was collected into a glass tube and evaporated at 
60°C under a gentle steam of nitrogen; 






  LC conditions 
 
The mobile phases used were different from the final method: A1 water; B1 acetonitrile, 
using the same column and same gradient specified in the final set-up method (see 3.2.7 
Analytical conditions). 
 
 MS conditions 
 




It was decided to compare four different clean-up methods to investigate the best one:  
 
 ―Only C18‖ cartridges: this protocol involved performing the above mentioned steps 
from 1 to 9, and then inject in the LC-MS/MS system. 
 ―C18 + NH2‖ cartridges: this protocol involved the execution of the above mentioned 
steps from 1 to 12, finally injection in LC-MS/MS system was performed. 
 ―MTBE (methyl- tert-butyl ether) + C18 cartridges‖: this protocol involved MTBE 
addition (2mL) after step 2, and performing the protocol only until step 9. 
 ―MTBE + C18+NH2 cartridges‖: this protocol involved MTBE addition (2mL) after step 
2, and then performing the protocol until step 12. 
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Three blank bovine hair samples were used: sample 646, 647, 647. This experiment was done 
in triplicate. 
 
Glassware and consumables 
 
 Several pipets; 
 Polypropylene (PP) tube 12 mL with screw cap (Greiner 163275); 
 12 mL glass tube (Beldico, 8739007); 
 10 mL glass tube with screw cap (16 x 100 mm Kimble/Kimax USA 45066A-16100); 
 Polypropylene tube 50 mL with screwcap (Greiner 210261); 
 Glass 2 mL HPLC vial (Waters 186000327c); 
 SPE Bond Elut C18  (50 mg, 3 mL; Agilent, USA); 
 Bond Elut-NH2 (1g, 6 mL; Agilent, USA); 




See 3.2.4 section. 
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 Acetonitrile (Biosolve 01203502); 
 MeOH (Biosolve 13683502); 
 Tris(2-carboxyethyl)phosphine hydrochloride (TCEP) (≥98%) (Sigma-Aldrich, St 
Louis MO, USA); 
 Acetone (Biosolve BV, The Netherlands); 
 Proteinase K from Tritirachium (>800 units/mL, Sigma Aldrich, St Louis MO, 
USA). 
 Tris-buffer (hydroxymethyl aminomethane) (Merck, Darrmstadt, Germany); 
 sodium hydroxide solution (Sigma Aldrich, St Louis MO, USA). 
 
 Standard solutions 
 
 ISS I 0.1 mg/L: 100 µL of each internal standard solution were pipetted into a 
volumetric flask of 10 mL and made up to volume with MeOH. This solution 




See 3.2.5 section. 
 
 Prepared solutions 
 
 MeOH/water 40/60 v/v: 40 mL MeOH were mixed in 60 mL of water.  
This solution was stored at room temperaturefor three months period of storage; 
 MeOH/water 80/20 v/v: 80 mL MeOH were mixed in 20 mL of water.  
This solution was stored at room temperaturefor three months period of storage; 
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 acetone/MeOH 80/20 v/v: 80 mL of acetone were mixed in 20 mL MeOH.  
This solution was stored at room temperaturefor three months period of storage; 
 Tris-Buffer solution 50 mM: 0.6057 g of Tris-Buffer were dissolved in 100 mL of 
water. This solution was stored at room temperature for three months period of 
storage. 
 Proteinase K: 40 mg of this enzyme were dissolved in 20 mL Tris-Buffer solution 
50 mM. 
 Sodium hydroxide 2M: 2 mg NaOH were dissolved in 25 mL of water. This 




 Sample pretreatment, sample series composition 
 
See section 3.2.6. No MMS and MMRS were prepared for this experiment. 
 
 
 MMS preparation 
 
No MMS and MMRS were prepared for this experiment. 
 
 Sample preparation 
 
See 3.2.6 section. 
 
 Extraction methods  
 
Three different extraction methods were tested: 
 
1. ―TCEP‖ protocol: the same extraction method which was performed in 
―Experiment A‖, for the protocol see 3.2.9.1 section, except for the 




2. ―Proteinase K‖ protocol:  
 200 mg of bovine hair were weighed accurately in 15 mL in 
polypropylene tube (PP), subsequently they were spiked with 30 
μL ISS I (0.1 mg/L); 
 1850 L Tris Buffer and 150 L Proteinase K were added. The 
final pH was adjusted to 7.4 pH using few drops of 2M sodium 
hydroxide solution; 
 Samples were placed in shaker at 37°C overnight; 
 4 mL MeOH were added, subsequently samples were vortexed 
and centrifuged for 5 min at 1700 G; 
 supernatant was collected in a new PP tube; 
 5 mL of water were added and samples were vortexed for few 
seconds. 
 
3. ―ACN overnight‖ protocol: 
 
 200 mg of bovine hair were weighed accurately in 15 mL in 
polypropylene tube (PP), subsequently they were spiked with 30 
μL ISS I (0.1 mg/L); 
 2 mL ACN were added to each sample;  
 samples were put in an ultrasonic bath at 40 °C overnight; 
 5 mL of water were added, subsequently samples were vortexed 
and centrifuged for 5 min at 1700 G; 
 supernatant was collected in a new PP tube; 




 Sample clean-up 
 





  LC conditions 
 
See Experiment A.  
 
 MS conditions 
 




It was decided to compare three different extraction methods (in triplicate) to investigate 
which was the best one. 
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The same blank bovine hair sample was used. This experiment was done in triplicate. 
 
Glassware and consumables 
 
 Several pipets; 
 Polypropylene (PP) tube 12 mL with screw cap (Greiner 163275); 
 12 mL glass tube (Beldico, 8739007); 
 10 mL glass tube with screw cap (16 x 100 mm Kimble/Kimax USA 45066A-16100); 
 Polypropylene tube 50 mL with screwcap (Greiner 210261); 
 Glass 2 mL HPLC vial (Waters 186000327c); 
 IAC easi-extract zearalenone (R-Biopharm Rhône LTD RP90); 




See 3.2.4 section. 
 








 Acetonitrile (Biosolve 01203502); 
 MeOH (Biosolve 13683502); 
 Tris(2-carboxyethyl)phosphine hydrochloride (TCEP) (≥98%) (Sigma-Aldrich, St 
Louis MO, USA); 
 Acetone (Biosolve BV, The Netherlands); 
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 Standard solutions 
 
 ISS I 0.1 mg/L: 100 µL of each internal standard solution were pipetted into a 
volumetric flask of 10 mL and made up to volume with MeOH. This solution 




See 3.2.5 section. 
 







 Sample pretreatment, sample series composition 
 
See section 3.2.6. No MMS and MMRS were prepared for this experiment. 
 
 MMS preparation 
 
No MMS and MMRS were prepared for this experiment.  
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 Sample preparation 
 
See 3.2.6 section. 
 
 Extraction methods  
 
Three different extraction methods were tested: 
 
1. ―MeOH overnight‖ protocol:  
 
 200 mg of bovine hair were weighed accurately in 15 mL in 
polypropylene tube (PP), subsequently they were spiked with 30 μL 
ISS I (0.1 mg/L); 
 2mL MeOH were added, subsequently samples were vortexed and 
were put in an ultrasonic bath at 40 °C overnight; 
 5 mL of water were added, then samples were vortexed for few 
seconds and subsequently centrifuged for 5 min at 1700 G; 
 supernatant was collected in a new PP tube; 
 5 mL of water were added and samples were vortexed for few 
seconds. 
 
2. ―ACN overnight‖ protocol: the method performed was previously described 
in Experiment B ―ACN overnight‖; 
 
3. ―TCEP‖ protocol: the method performed was previously described in 
Experiment A ―TCEP‖(Experiment A). 
 
 
 Sample clean-up 
 
A different clean-up was utilised involving the immunoaffinity columns (IACs), for the 






  LC conditions 
 
See section Experiment A. 
 
 MS conditions 
 




Three different extraction protocols, which adopted a new clean-up methods (IACs), were 









The same blank bovine hair sample was used. This experiment was done in triplicate. 
 
Glassware and consumables 
 
 Several pipets; 
 Polypropylene (PP) tube 12 mL with screw cap (Greiner 163275); 
 12 mL glass tube (Beldico, 8739007); 
 10 mL glass tube with screw cap (16 x 100 mm Kimble/Kimax USA 45066A-16100); 
 Polypropylene tube 50 mL with screwcap (Greiner 210261); 
 Glass 2 mL HPLC vial (Waters 186000327c); 
 IAC easi-extract zearalenone (R-Biopharm Rhône LTD RP90); 
 SPE Bond Elut C18  (50 mg, 3 mL; Agilent, USA); 
 Bond Elut-NH2 (1g, 6 mL; Agilent, USA); 




See 3.2.4 section. 
 








 Acetonitrile (Biosolve 01203502); 
 MeOH (Biosolve 13683502); 
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 Tris(2-carboxyethyl)phosphine hydrochloride (TCEP) (≥98%) (Sigma-Aldrich, St 
Louis MO, USA); 
 Acetone (Biosolve BV, The Netherlands); 
 
 Standard solutions 
 
 ISS I 0.1 mg/L: 100 µL of each internal standard solution were pipetted into a 
volumetric flask of 10 mL and made up to volume with MeOH. This solution 




See 3.2.5 section. 
 
 Prepared solutions 
 
 MeOH/water 40/60 v/v: 40 mL MeOH were mixed in 60 mL of water.  
This solution was stored at room temperaturefor three months period of storage; 
 MeOH/water 80/20 v/v: 80 mL MeOH were mixed in 20 mL of water.  
This solution was stored at room temperaturefor three months period of storage; 
 acetone/MeOH 80/20 v/v: 80 mL of acetone were mixed in 20 mL MeOH.  





 Sample pretreatment, sample series composition 
 
See section 3.2.6. No MMS and MMRS were prepared for this experiment. 
 
 
 MMS preparation 
 
No MMS and MMRS were prepared for this experiment.   
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 Sample preparation 
 
See 3.2.6 section. 
 
 Extraction methods  
 
Three different extraction methods were tested: 
 
1. ―IAC extraction‖ protocol: same of ―MeOH overnight‖ (Experiment C); 
2. ―C18+NH2 (MeOH)‖ protocol: same of ―MeOH overnight‖ (Experiment C); 
3. ―C18+NH2 (TCEP)‖ protocol: same of ―TCEP‖ protocol (Experiment B); 
 
 Sample clean-up 
 
1. ―IAC extraction‖ protocol: it was performed IACs clean-up (see Experiment 
C); 
2. ―C18+NH2 (MeOH)‖ protocol: it was performed C18+NH2 clean-up method 
(see Experiment A); 






  LC conditions 
 
See Experiment A. 
 
 MS conditions 
 




Different extraction/clean-up methods were tested to investigate which was the best one. 
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3.2.9.2 LC conditions set-up  
 




Samples from previous experiments (A-D) were used. 
 






See 3.2.4 section. 
 








Acetonitrile (Biosolve 01203502); 
Ammonium formate 97% (Sigma-Aldrich, St Louis MO, USA, 15.626-4); 
 






See 3.2.5 section.  
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 Prepared solutions  
 
 MeOH/water 40/60 v/v:  400 mL MeOH were mixed in 600 mL of water. This 
solution was stored at room temperature for three months period of storage. 
 
 Ammonium formate 1 M LC-MS grade: 6.3 gram of ammoniumformate were 
dissolved in 100 mL of water. This solution was stored at room temperature for 
three months period of storage. 
 
 ACN/water 90/10 (v/v) LC-MS grade: 900 mL ACN were mixed with 100 mL 









 LC conditions 
 
In this experiment were optimised: 
  
 mobile phases: 
 
samples from previous experiments were injected both with: 
 
 A: water,  
B: acetonitrile; 
 A: 2mM Ammonium Formiate, 0.05% Formic Acid, in H2O,  





 flow rate  
 





3.2.10 Applicability of the method on human hair 
 
The applicability of the method set-up on bovine hair was also tested on human hair to perform: 
 one day validation; 
 applicability of the method for the analysis of other human hair samples. 
The protocol was adapted from the bovine hair method (See 3.2 Materials and Methods), so only 
small changes to the bovine method were applied. 
 
 List of abbreviations 
 




Human hair samples were collected from eight volunteers from the Gelderland area, 
during regular hair cuts (The Netherlands).  
 
 One day validation 
Both blond, brown, white hair samples were collected between April-July 2017. 
Samples were stored in aluminium foils at room temperature, under dry and dark 










Table 15. Donors‘ human hair sample information. 
 
Hair Characteristics 
A Woman 21 years old 
B Woman 52 years old 
C Boy 6 years old 
D Man 21 years old 
E Man 75 years old 
F Woman 48 years old 
G Boy 17 years old 
H Man 63 years old 
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 Applicability of the method for the analysis of other human hair samples 
Both blond, brown, white hair samples were collected between April-July 2017. 
Samples were stored in aluminium foils at room temperature, under dry and dark 


























Hair Characteristics Country 
A Woman 20 years old The Netherlands 
B Woman 59 years old The Netherlands 
C Boy 15 years old The Netherlands 
D Man 63 years old The Netherlands 
E Woman 50 years old The Netherlands 
F Woman 52 years old The Netherlands 
G Man 26 years old The Netherlands 
H Woman 65 years old The Netherlands 
I Man 65 years old Italy 
J Man 73 years old The Netherlands 
K Boy 11 years old The Netherlands 
I Woman 71 years old The Netherlands 
L Woman 67 years old The Netherlands 
M Woman 30 years old Italy 
N Man 23 years old The Netherlands 
O Man 62 years old The Netherlands 
P Man 27 years old Germany 
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 Glassware and consumables 
 
 Several pipets; 
 Polypropylene (PP) tube 12 mL with screw cap (Greiner 163275); 
 Whatman 595 ½ folded filters (diameter 150 mm) (GE Healthcare Life Sciences); 
 12 mL glass tube (Beldico, 8739007); 
 10 mL glass tube with screw cap (16 x 100 mm) (Kimble/Kimax USA 45066A-16100); 
 Polypropylene tube 50 mL with screwcap (Greiner 210261); 
 Glass 2 mL HPLC vial (Waters 186000327c); 
 IAC easi-extract zearalenone (R-Biopharm Rhône LTD RP90); 
 
 Lab equipment 
 
See 3.2.4 section.  
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Acetonitrile (Biosolve 01203502); 
Ammonium formate 97% (Sigma-Aldrich, St Louis MO, USA, 15.626-4); 
Dichloromethane 99.8% (ActuAll Chemicals, Randneer, The Netherlands); 
Methanol (Biosolve 13683502); 
PBS (Sigma-Aldrich, St Louis MO, USA, P-5368); 
Tris(2-carboxyethyl)phosphine hydrochloride (TCEP) (≥98%) (Sigma-Aldrich, St 
Louis MO, USA); 
 
 Standard solutions 
 
o Stock standard solutions 1000 mg/L: each standard was prepared by 
dissolving accurately (between 1 and 5 mg ± 0.02 mg) in MeOH. Stock 
solutions were stored in a freezer for two years period of storage. 
 
o MSS I 10 mg/L: 100 µL of each standard stock solution were pipetted into a 
volumetric flask of 10 mL and made up to volume with MeOH. This solution 
was stored in a refrigerator for six months period of storage. 
 
o MSS II 0.1 mg/L: 100 µL of MMS I were pipetted into a volumetric flask of 
10 mL and made up to volume with MeOH. This solution was stored in a 
refrigerator for one month period of storage. 
 
o MSS III 0.01 mg/L: 100 µL of MMS II were pipetted into a volumetric flask 
of 10 mL and made up to volume with MeOH. This solution was stored in a 
refrigerator for one month period of storage. 
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o MSS IV 0.001 mg/L: 100 µL of MMS III were pipetted into a volumetric 
flask of 10 mL and made up to volume with MeOH. This solution was stored 
in a refrigerator for one month period of storage. 
 
o Stock solution internal standard I 10 mg/L: 1 mL MeOH was added to each 
ampoule, placed subsequently in an ultrasonic bath for one minute. Thus it 
was mixed and transferred in a 5 mL and 10 mL flasks. The content was filled 
up with MeOH and mixed. The stock solutions were stored in a freezer for 
five years period of storage. 
 
o Stock solutions internal standard II 1000 mg/L: 0.5 mL MeOH was pipetted 
in a vial containing zearalanone-d6 internal standard and 1.0 mL MeOH was 
pipetted in a vial containing zearalenone-d6 internal standard. These solutions 
were mixed, vortexed and stored in a freezer for five years period of storage. 
 
o ISS I 10 mg/L: 100 µL of each internal standard stock solution 1000 mg/L 
was pipetted in a 10 mL volumetric flask and made up to volume with 
MeOH. This solution was stored in refrigerator for six months period of 
storage. 
 
o ISS II 0.1 mg/L: 100 µL of each internal standard stock solution ISS I 10 
mg/L were pipetted and put into a volumetric flask of 10 mL, made up to 
volume with MeOH. This solution was stored in refrigerator for one month 
period of storage. 
 
o ISS III 0.01 mg/L: 100 µL of each internal standard stock solution ISS II 10 
mg/L were pipetted and put into a volumetric flask of 10 mL, made up to 
volume with MeOH. This solution was stored in refrigerator for one month 
period of storage. 
 
o working standard solution: 80 µL MSS IV and 40 µL ISS III were pipetted in 
a glass tube. This solution is spiked at the same level as MMRS. This solution 





See 3.2.5 section. 
 
 Prepared solutions 
 




 Sample preparation and sample series 
 
 Sample pretreatment 
 
Human hair were undergone to a decontamination step prior the extraction 
phase. 
o 1 g of hair was weighed and placed in a falcon tube; 
o 20 mL MilliQ water were first added to each sample, mixed for 5 minutes 
under head over head rotator; 
o hair samples were dried on folded filter paper for 2 hours; 
o 20 mL dichloromethane were first added to each sample, mixed for 5 
minutes under head over head rotator; 
o hair samples were dried on folded filter paper for 30 minutes; 
o hair samples were pulverised through the use of ball mill and a bucket 
(equipped with 5 balls) which was filled with 500 mg hair. The content 
was pulverised for 4 minutes at 25 Hz and transferred in a 12 mL 
polypropylene (PP) tube. 
 
 Sample series composition for each validation day 
 
o 7 blank hair samples which were spiked before processing (MMS), 
according to table 17; 
o blank samples which were included in each series; 
o hair samples; 
o blank hair sample which was spiked with matrix standard solution only 
after processing (MMRS), according to table 17; 
o working standard solution. 
 
 MMS, MMRS preparation  
 
Calibration was performed using MMS samples, while recovery rate was obtained 
using MMRS sample. Hair samples were weighed and put in polypropylene tubes 
(12 mL); subsequently samples were spiked with standard solution (normal 
standard and internal one), according to table 17. Then spiked samples were 
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Table 17. MMS and MMRS spiking levels. 
 
 
 Sample preparation 
 




See section 3.2.6. 
 
 Sample clean-up IAC 
 




µL MSS IV 
(0.001 mg/L) 
µL MSS III 
(0.01 mg/L) 
µL ISS III 
(0.01 mg/L) 
MMS A (0 µg/kg)   20 
MMS B (0.025 µg/kg) 10  20 
MMS C (0.05 µg/kg) 20  20 
MMS D (0.1 µg/kg) 50  20 
MMS E (0.1 µg/kg)  10 20 
MMS F (0.5 µg/kg)  20 20 
MMS G (1 µg/kg)  40 20 
MMRS (0.2 µg/kg) 40  20 
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 Analytical conditions 
 
 LC conditions 
 
See section 3.2.7. 
 
 MS conditions  
 




3.2.11 Method validation on human hair 
 
A one-day validation was carried out. 
 
 Human validation scheme 
 




Table 18. Validation scheme for one-day validation.  
Sample type Letter Number 
St mix  
µg/kg 
    Sample B 23 0.2 
Sample C 24 0.2 
Sample D 25 0.2 
Sample E 26 0.2 
Sample F 27 0.2 
Sample G 28 0.2 
Sample H 29 0.2 
    Sample B 30 0.5 
Sample C 31 0.5 
Sample D 32 0.5 
Sample E 33 0.5 
Sample F 34 0.5 
Sample G 35 0.5 
Sample H 36 0.5 
    Sample B 37 0.2 
Sample B 38 0.2 
Sample B 39 0.2 
Sample B 40 0.2 
Sample B 41 0.2 
Sample B 42 0.2 
Sample B 43 0.2 
    
Sample type Letter Number 
St mix  
µg/kg 
    MMS A 1 0 
MMS A 2 0.05 
MMS A 3 0.1 
MMS A 4 0.25 
MMS A 5 0.5 
MMS A 6 1.0 
MMS A 7 2.0 
    MMRS A 8 0.2 
    Sample B 9 0 
Sample C 10 0 
Sample D 11 0 
Sample E 12 0 
Sample F 13 0 
Sample G 14 0 
Sample H 15 0 
    Sample B 16 0.1 
Sample C 17 0.1 
Sample D 18 0.1 
Sample E 19 0.1 
Sample F 20 0.1 
Sample G 21 0.1 
Sample H 22 0.1 
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 Criteria for individual samples 
 




See section 3.2.8. 
 
 Validation criteria 
 
See section 3.2.8. (See Table 19). 
Since no MRLs have been established for zearanols determination in human hair a guide 








   Table 19. Different parameters tested during one-day validation. 
 
 
 Linearity: 7x the same sample at 0 - 0.05 - 0.1 – 0.25 – 0.5- 1.0- 2.0 µg/kg. 
 Recovery: 1x same sample as used for linearity after reprocessing at 1 x GV. 
 Trueness: 7 * 3 samples at 0.5 - 1 - 2.5 x GV. 
 Within-laboratory reproducibility: 7 different samples at 0.5 - 1 - 2.5 x GV. 
 Intra-day repeatability: 7 x the same sample at 1 x GV. 
 CCα / CCβ: 7 * 3 samples at 0.5 - 1 - 2.5 x GV. 
















1 7 (A) 7*3 (B-H) 7*(1xGV) B 7 (B-H) 
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3.3 RESULTS  AND  DISCUSSION 
 
Based on current state-of-the-art literature, this was the first work which identified zearalenone 
and its main metabolites in bovine and human hair using LC-MS/MS, moreover this research 
evaluated the suitability of this non-conventional matrix for biomonitoring studies. 
As specified earlier, hair analysis is a promising alternative to improve the success of surveillance 
plans, offering multiple advantages compared to other biological matrices (liver, blood, kidney), 
because it a non-invasive, easy, low cost procedure which can give information about short and 
long time exposure (Schramm 2008; Esteban & Castaño 2009; Fernández et al. 2014). 
Livestock biomonitoring could be important to better understand human exposure to 
mycotoxins, since this phenomenon may result from contamined plant-derived feed, and leading 
to carry-over into animal products, such as meat, eggs and milk. 
Moreover the set-up method on bovine and human hair can provide useful information 
regarding zearalenone and its metabolites‘ occurrence in feedstuffs and foodstuffs, which can 
represent a huge impact on the agri-food sector and the economy. 
The current research could represent a useful tool to evaluate natural feed contamination or 
detect not legal use of α-zearalanol in bovine, and to conduct an initial inventory of the 
occurrence of RALs as biomarkers for ZEA exposure in bovine and human hair in future 
studies. 
 
3.3.1 Set-up and validation method in bovine hair 
 
A multiresidual method was set-up to identify -ZAL, -ZAL, ZEA, ZAN, -ZEL, -ZEL in 
bovine hair, using LC-MS/MS technique.  
The developed method was suitable to identify all six analytes, which showed satisfactory 
recoveries ( 79%), good linearity (R2  0.99) and selectivity. 
However the method was validated only for three analytes of interest (α -zearalanol, ß-
zearalanol, zearalanone), according to European Union Decision 2002/657/EC (European 
Commission 2002). 
 
For the results of the three validation days (see tables 20, 21 and 22) for the three different 


































Day 1 Day 2 Day 3 
    
0.5 0.56 0.50 0.52 
0.5 0.55 0.51 0.52 
0.5 0.58 0.48 0.46 
0.5 0.57 0.48 0.48 
0.5 0.55 0.48 0.44 
0.5 0.56 0.47 0.49 
0.5 0.60 0.52 0.50 
1 1.01 1.04 1.04 
1 1.10 1.04 1.03 
1 1.08 1.10 1.09 
1 0.99 1.08 1.05 
1 1.06 1.05 1.09 
1 1.12 1.04 1.07 
1 1.10 1.04 1.03 
1.5 1.65 1.53 1.65 
1.5 1.60 1.58 1.60 
1.5 1.58 1.53 1.52 
1.5 1.54 1.52 1.64 
1.5 1.67 1.52 1.61 
1.5 1.58 1.52 1.57 







































Day 1 Day 2 Day 3 
    
0.5 0.46 0.48 0.44 
0.5 0.51 0.53 0.48 
0.5 0.54 0.48 0.44 
0.5 0.55 0.46 0.40 
0.5 0.54 0.52 0.45 
0.5 0.54 0.53 0.50 
0.5 0.56 0.42 0.51 
1 1.10 1.00 1.14 
1 1.08 1.13 1.08 
1 1.11 1.04 1.09 
1 1.09 1.01 1.08 
1 1.01 1.03 1.09 
1 1.09 1.09 1.05 
1 1.10 0.98 1.05 
1.5 1.93 1.54 1.60 
1.5 1.45 1.62 1.67 
1.5 1.41 1.51 1.66 
1.5 1.58 1.49 1.75 
1.5 1.63 1.61 1.66 
1.5 1.60 1.47 1.65 






































Day 1 Day 2 Day 3 
    
0.5 0.64 0.50 0.43 
0.5 0.47 0.56 0.48 
0.5 0.73 0.50 0.41 
0.5 0.51 0.49 0.48 
0.5 0.50 0.54 0.41 
0.5 0.55 0.55 0.46 
0.5 0.61 0.55 0.61 
1 1.30 1.03 1.00 
1 1.33 1.18 0.99 
1 1.13 1.20 1.08 
1 0.87 1.26 1.07 
1 1.02 1.27 1.03 
1 1.11 1.19 0.96 
1 1.15 1.22 1.37 
1.5 1.30 1.66 1.55 
1.5 1.86 1.86 1.39 
1.5 1.42 1.70 1.47 
1.5 1.39 1.79 1.55 
1.5 1.48 1.93 1.46 
1.5 1.49 1.76 1.45 














Table 23. Trueness, RSDr (Repeatability) and RSDRL (Within-laboratory reproducibility) based on  








Table 24. RSDr based on three validation days (ANOVA method, 7 x the same hair). 
 
For zearalanone, trueness lied between 104.6 and 113%, for α-Zearalanol between 103.1 and 
105.9%, for ß-Zearalanol between 98.5 and 106.8% (table 23). 
For all compounds both the RSDr and RSDRL (%) complied with the criteria (see 3.2.8 section), 
moreover also RSDr based on three validation days is satisfactory (table 24). 
Zearalanone had an outlier according to Grubb's test. This value was not included in 
calculations. 
  
Compounds Level µg/kg Trueness (%) RSDr (%) RSDRL (%) 
Zearalanone 0.5*GV 0.5 104.6 13.1 15.7 
 1.0*GV 1.0 113.0 11.4 11.9 
 1.5*GV 1.5 107.8 10.2 13.4 
α-Zearalanol 0.5*GV 0.5 103.1 4.3 9.5 
 1.0*GV 1.0 105.9 3.3 3.5 
 1.5*GV 1.5 105.0 2.6 3.6 
ß-Zearalanol 0.5*GV 0.5 98.5 7.8 10.1 
 1.0*GV 1.0 106.8 3.7 4.1 
 1.5*GV 1.5 106.8 6.9 7.9 
Compounds Level µg/kg RSDr (%) 
Zearalanone 1.0*GV 1.0 9.5 
α-Zearalanol 1.0*GV 1.0 5.4 
ß-Zearalanol 1.0*GV 1.0 6.4 
 104 
CCα and CCβ 
 
The calculation of CCα and CCβ was performed in accordance with the Decision 2002/657/EC.  







Zearalanone 0.48 0.95 
α-Zearalanol 0.11 0.23 
ß-Zearalanol 0.27 0.53 
 
Table 25. Calculated CCα and CCß. 
 
CCα and CCß were found to be equal or better than the lowest concentration level included in 





In almost all blanks samples zearalenone α-zearalenol and ß-zearalenol were found. These 
compounds probably derived from mouldy food that the cattle have eaten. Traces of 
zearalanone, α-zearalanol and ß-zearalanol were detected in three of the blanks used. These 
values have been corrected. 
It was found also that: 
 zearalanone and bromchlorbuterol have the same parent, however, bromchlorbuterol has 
others daughter ions and is measured in the positive mode; 
 α-zearalanol, ß-zeralanol and chloramphenicol have the same parent, but they have 
different daughters. 
Thus the method was selective to determine zearalanone, α-zearalanol and ß-zearalanol with a 









Only zearalanon from MMRS 408668 did not meet the criteria after one week of storage in the 
freezer. The other components comply after one and two weeks in the freezer. 
After the reinjections of samples run during the day 3 validation, the differences were tested 
against the repeatability obtained via Resval and difference in accordance with MMRS (<15%). 
Almost all differences of all re-injections were smaller than repeatability.  
Despite of some deviations it can be concluded that extracts can still be analysed in the freezer 




In the three series of the three validation days and in reinjections after one week linearity criteria 


















The recovery of the analytes was determined with a different sample on each validation day. The 
results are shown in table 27. 
 
 
Table 27. Recovery per validation day and average recovery. 
 
Zearalanone recovery values ranged from 72 to 85%, α-zearalanol between 72 and 90%, ß-
zearalanol 81 and 82%. The latter one displayed better recoveries values. 
However the results were satisfactory. 
  
Compounds Day 1 Day 2 Day 3 Mean 
Zearalanone 72 81 85 79 
α-Zearalanol 72 76 90 79 




The matrix effect of the analytes was determined by comparing a sample with spike after sample 
pre-treatment (MMRS) with a standard solution at a corresponding concentration level.  
The matrix effect is determined for each batch on each validation day. At a value lower than 100 
there is suppression. With a value higher than 100, there is enhancement. A summary of the 
results is shown in table 28. 
 
Compounds Day 1 Day 2 Day 3 Mean 
Zearalanone 133 193 103 143 
α-Zearalanol 110 163 92 122 
ß-Zearalanol 107 127 87 107 
 
Table 28. Suppression and enhancement of zeranols. 
 
For zearalanone in both three validation days has been displayed an enhancement of the signal, 
moreover α-Zearalanol and ß-Zearalanol showed an enhancement during the validation day 1, 
and 2. Day 3 validation was characterised by the lowest matrix effect values. 
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The additional MTBE step (graph 1) did not bring any significant enhancement to the protocol 
in all analytes, so it was decided to perform further future modifications to the extraction 




Graph 1. Response factor (Standard Area/Internal Standard Area) of different clean-up methods: 
C18+NH2, C18, TBME C18+NH2, TBME C18. 
  
 109 
Tris(2-carboxyethyl)phosphine hydrochloride (TCEP) was employed in these protocols because 
it was reported it could reduce disulfide bridges of hair protein structure (Getz et al. 1999). 
Moreover it has been used in animal hair for drugs, steroid esters analysis and steroids analysis in 
human hair (Hooijerink et al. 2005; Nielen et al. 2006; Pozo et al. 2009).  
Methyl-tert-butyl ether (MTBE) was also used in this experiment because many authors reported 
it improved extraction efficiency in bioanalysis for pharmaceutical compounds, moreover it has 
been used for drugs and growth promoters analysis in hair (Duffy et al. 2009; Regal et al. 2010; 





The performance of the three different extraction methods was compared (graph 2): there was 
not a huge difference among the three protocols, moreover the signal to noise ratio was also 





Graph 2. Response factor (Standard Area/Internal Standard Area) of different extraction methods: 
TCEP, Proteinase K and ACN overnight. 
 
 
Proteinase K, a digestion enzyme with proven keratin hydrolyzing activity, was employed for the 
determination of drugs in human hair, and anabolic agents in bovine hair (Höld et al. 1998; 





The Proteinase K protocol that was performed, was adapted from the optimised method set-up 






Due to troubles generated by the PBS washing step, which did not allow a good sensitivity, many 
preliminary experiments were performed to set-up the IACs final protocol which involved. 
PBS and water were tested in different volumes to wash IACs in order to minimize non-specific 




Graph 3. Response factor (Standard Area/Internal Standard Area) of different extraction methods 




Both MeOH and ACN overnight extractions gave better responses, in comparison to the TCEP 
protocol; in addition immunoaffinity colums, although they represent an expensive clean-up 
method, provided good results in term of sensitivity and selectivity (graph 3). 
IACs clean-up method was chosen because it had been performed previously to determine 
zearalenone and metabolites in many different biological matrices such as urine, plasma, faeces, 
which improved the selectivity of sample preparation (Songsermsakul et al. 2006).  
Moreover IACs can show multiple advantages (Mateo et al. 2002):  
 they can produce cleaner extracts due to the specificity of the antibodies towards a single 
or a group of mycotoxins; 
  they are characterised by good accuracy and precision within a wide range of 
concentrations;  







Graph 4. Response factor (Standard Area/Internal Standard Area) of different extraction/clean-up 
methods: MeOH extraction (IACs), MeOH extraction (C18+NH2), TCEP extraction (C18+NH2).  
 
MeOH extraction followed by IACs or the C18+NH2 method gave the better responses 
compared to the TCEP one (graph 4).  
For the final extraction method it was decided to not use TCEP, since it did not improve the 
protocol in terms of sensitivity. 
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The IACs clean-up method was chosen as the definitive method for the high sensitivity 
achieved, high recovery and the reduced time of analysis, compared to that one of C18+NH2  




New mobiles phases were chosen: 
• A: 2mM Ammonium Formiate, 0.05% Formic Acid, in H2O 
• B: 2mM Ammonium Formiate, 0.05% Formic Acid, in ACN: H2O (90:10) 
These ones gave better responses in terms of sensitivity and peak shapes, compared to A: water - 
B: acetonitrile. 
 
Moreover, due to costant overpressure problem with the column, different flow rates were 




3.3.3 Set-up and one day validation on human hair 
 
The present work reported a sensitive method for the quantification of zearalenone, α -
zearalanol, ß-zearalanol, α-zearalenol, ß-zearalenol, zearalanone in human hair (figure 9) based 
on an LC-MS/MS technique. The method was validated through a one validation day. 
Based on the current state-of-the-art literature, this work identified for the first time zearalenone 













Figure 9. Human hair drying process after dichloromethane washing step: ―white crystals‖ formation on 
hair was noticed, probably formed as a result of the heat loss during evaporation of the solvent. 
 
 
Trueness, repeatability, whitin-lab reproducibility 
 
The validation parameters of repeatability and inner-draft producibility were determined on the 
basis of 7 blank samples with additions prior to work-up of 0.5, 1 and 2.5 times the guide value 
and on the basis of one blank sample in sevenfold with addition before work-up of 1 time the 
guide value (GV) (tables 29 and 30).  

























Table 29. Trueness, RSDr (repeatability) and RSDRL (whitin-laboratory reproducibility) based on 
one test day (seven different human hairs).  








0.5*GV 0.1 112 13.1 20.9 
1.0*GV 0.2 102 11.0 17.5 
2.5*GV 0.5 95 9.0 14.4 
α-Zearalanol 
0.5*GV 0.1 123 20.8 33.2 
1.0*GV 0.2 108 7.9 12.7 
2.5*GV 0.5 109 7.2 11.5 
ß-Zearalanol 
0.5*GV 0.1 117 14.7 23.5 
1.0*GV 0.2 104 5.8 9.2 
2.5*GV 0.5 99 7.7 12.2 
       Zearalenone 
0.5*GV 0.1 105 12.7 20.4 
1.0*GV 0.2 95 3.5 5.6 
2.5*GV 0.5 100 6.3 10.0 
α-Zearalenol 
0.5*GV 0.1 135 23.3 37.2 
1.0*GV 0.2 108 14.5 23.2 
2.5*GV 0.5 97 7.9 12.7 
ß-Zearalenol 
0.5*GV 0.1 136 23.5 37.6 
1.0*GV 0.2 85 8.0 12.8 
2.5*GV 0.5 107 14.2 22.7 
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All bold printed values did not meet the requirements set in the validation plan. Instead, the 
slightly too high values were accepted. 
For all analytes trueness, RSDr, RSDRL displayed satisfying values at 1.0 and 2.5 GV, in 
accordance with the criteria specified (see Validation criteria, 3.3.1 section). While α-Zearalanol, 
α-Zearalenol, ß-Zearalenol did not show acceptable values at 0.5 GV, so the method still needs 











Table 30. RSDr based on one test day (Anova method, 7 x the same hair). 
 
For all analytes RSDr on the same hair displayed satisfactory results, in accordance with the 





Compounds Level µg/kg RSDr (%) 
Zearalanone 1.0*GV 0.2 6.7 
α-Zearalanol 1.0*GV 0.2 8.1 
ß-Zearalanol 1.0*GV 0.2 6.1 
Zearalenone 1.0*GV 0.2 9.1 
α-Zearalenol 1.0*GV 0.2 14.4 
ß-Zearalenol 1.0*GV 0.2 17.8 
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CCα and CCβ 
 
The calculation of CCα and CCβ was performed in accordance with the Decision 2002/657/EC.  















Selectivity represents the discrimination between the analyte and closely related substances (e.g.. 
isomers) or matrix interferents. In total 7 blank hair without the addition of the zeranols with 
only the internal standard were spiked and assessed for the presence or absence of a signal on 
the expected retention times. There were no disturbances on the retention times of the 




For β-zearalenol and zearalanone, too low linearity was found in the MMS line for the samples 








Zearalanon 0.09 0.17 
α-Zearalanol 0.07 0.15 
ß-Zearalanol 0.07 0.14 
Zearalenon 0.06 0.11 
α-Zearalenol 0.10 0.21 




The recovery of the analytes was determined with a different sample on each validation day. The 










Table 32. Recovery in human hair. 
 
The recovery rates still need to be improved and optimized, specially for α-zearalenol, 
zearalanone, zearalenone, α-zearalanol. 
 
 
3.3.4 Applicability of the method for the analysis of human hair samples  
 












4. MYCOTOXINS IN PET FOOD FOR 
CATS 
 
4.1 PROJECT INTRODUCTION 
 
4.1.1 Pet food for cats and mycotoxin risk 
 
Pets play an important role in families, with purely emotional and other supporting functions in 
everyday life (Assalco 2017). In view of the intense human-animal companion bond and 
enhanced health awareness, as well as a greater consideration regarding pet welfare, the pet food 
industry is making so much efforts to pursue sustainability in food system, which implies also 
such as food quality and safety (Walsh 2009; Swanson et al. 2013). 
In Western Europe cats are the most popular domestic animals: they are strictly carnivorous 
animals, moreover unlike other pets, cats need to have higher protein intake, which can affect 
both their food preferences and requirements. Thus their diet must contain specific nutrients, 
such as taurine, arginine, vitamin A, niacin, and arachidonic acid, without leaving out factors 
influencing food palatability (Zaghini & Biagi 2005). 
Mycotoxin contamination in pet food represents a relevant health issue to domestic animals. 
Cereal grains and nuts are the main components in pet food formulations for companion 
animals such as cats, dogs, fish, birds and rodents (Aquino & Correa 2011). 
There are types of commercial pet foods: dry, semi-moist, and moist or canned. The main 
difference relies on the water content of the food, for instance dry foods contain less than 11% 
water, semi-moist foods contain 25 to 35% water, finally moist or canned food contain 60 to 
87% water (Zicker 2008; Aquino & Correa 2011). 
Dry food particles are produced by the extrusion process, which uses the same technology 
utilised for breakfast cereals production. Other production methods include pelleting, baking, 
flaking and crumbling of raw materials to give them a dry form. Extruded food production 
involves a mixing and extrusion steps:. the ingredients are put into an extruder which utilises a 
combination of pressure (from 34 to 37 atm), steam and high temperature (between 100 to 
200°C) in a short period of time to quickly cook foods (Aquino & Correa 2011). 
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In general food processes can reduce mycotoxin concentrations significantly, but do not 
eliminate them completely. However extrusion and roasting processing could lower mycotoxin 
concentrations, even though very high temperatures are required to lessen mycotoxin 
concentrations. According to Bullerman & Bianchini (2007) extrusion cooking at high 
temperatures (more than 150°C) can result in a proper zearalenone reduction, moderate one of 
aflatoxins, variable to low reduction of deoxynivalenol and a good reduction of fumonisins 
(Bullerman & Bianchini 2007). 
However mycotoxin contamination represents a great concern in pet food, because the 
mycotoxins that can occur in cereals and other products cannot be completely degraded through 
food-processes and can still remain in the final product (Milani & Maleki 2014). 
Aflatoxins can be degraded by temperatures ranging from 237 °C to 306 °C, moreover it was 
reported that temperatures above 150 °C can lead to the partial destruction of the molecules. 
Deoxynivalenol is stable at 120 °C and moderately so at 180 °C; however it can be destroyed 
after 40 minutes at 210 °C (Samarajeewa et al. 1990; Rustom 1997; Milani & Maleki 2014). 
Zearalenone is a chemically stable substance with a melting point of 164-165 °C, moreover it was 
reported that it can resist to 4 hours of heat treatments at 120 °C. 
Fumonisins are quite heat stable and significant destruction occur during processes that are at 
temperatures greater than of 150 °C (Milani & Maleki 2014). 
Ochratoxin A seems to be stable up to 180 °C (Raters & Matissek 2008). Few studies 
investigated the mycotoxin effects on cat health.  
Newbern et al. reported that adult mixed-breed cats showed an aflatoxin B1 sensitivity similar to 
rabbit, dog and guinea pig, as a result of a single dose LD50 of 0.55 mg/kg. Deaths usually 
occurred after 48 – 72 hours. Furthermore gall bladder edema, abnormal growth and sometimes 
loose stools have also been found in cats (Newberne & Butler 1969). 
Hughes et al. investigated the effects of dietary DON on dogs and cats: food was refused by cats 
when DON levels exceeded 7.7 mg/kg, while in dogs 4.5 mg/kg. These findings indicated a 
lower sensitivity in cats than dogs. Moreover food consumption diminished at DON levels of 
7.5 μg/kg of cat food, and at 4.5 μg/kg of dog food (Hughes et al. 1999).  
The discrepancy shown between cats and dogs could be explained by the tendency of felines to 
consume small amounts of food over time, instead of dogs which are more likely to feed with 
voracity. Based on the findings it has been suggested that deoxynivalenol levels in pet food 
should not exceed 0.5 mg/Kg. However deoxynivalenol is not the only trichotecene on which to 
focus in pet toxicology (Zain 2011). 
Borison et al. intravenously administered T-2 toxin to cats at a concentration of 2 mg/kg, which 
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caused in hypovolemia and death, moreover, lower white blood cells content occurred at sub-
lethal T-2 toxin dose (Borison et al. 1991). 





Directive 2002/32/EC and subsequent amendments of the European Union set specific 
maximum limits for aflatoxin B1 (AFB1) in complete and complementary feeding stuffs 
intended for animals: the established value is 5 – 20 g/kg, which can be referred to products 
containing 12% moisture, with also several specifications for livestock animals (European 
Parliament and Council 2002). The feed category called ―other complete feedingstuffs‖ probably 
consists of pet foods products, for which a limit of 10 µg/kg has been established. 
In addition European legislation set recommendation regarding mycotoxin contamination in 
products intended from animal feed, on the basis of the different animal species considered.  
UE Recommendation 2016/1319, which emended the Decision 2006/576/CE, established 




o kittens, dogs and cats for reproduction: 100 µg/kg; 
o adult dogs and cats other than for reproduction: 200 µg/kg; 
 
 ochratoxin A 
o cats and dogs: 10 µg/kg; 
 
 fumonisins (FB1+FB2) 
o pet animals: 5000 µg/kg; 
 
 T-2 + HT-2 toxin: 
o compound feed for cats: 50 µg/kg; 
 
 deoxynivalenol: 




4.2 MATERIALS  AND  METHODS 
 
 
The present work was conducted to determine the presence and contamination level of most 
important mycotoxins in commercial cat dry food, using liquid chromatography coupled with 
tandem mass spectrometry (LC-MS/MS). 
This work was performed in collaboration with the ―Animal Productions and Food Safety 
Service‖ (SPASA) set in the DIMEVET (Veterinary Medical Sciences Department) in Ozzano 
dell¹Emilia, Bologna University. 
The examined mycotoxins were aflatoxin B1 (AFB1), aflatoxin B2 (AFB2), aflatoxin G1 
(AFG1), aflatoxin G2 (AFG2), deoxynivalenol (DON), zearalenone (ZEA), fumonisin B1 (FB1), 
fumonisin (FB2), ochratoxin (OTA), T-2 toxin (T2) and HT-2 toxin (HT2). 
In order to identify the risk mycotoxins can represent to the domestic cat, a survey study was 
conducted examining the levels of mycotoxins in sixty-four complete commercial extruded dry 




4.2.1 List of abbreviations 
 
AFB1: Aflatoxin B1 
AFB2: Aflatoxin B2 
AFG1: Aflatoxin G1 
AFG2: Aflatoxin G2 
DON: Deoxynivalenol 
FB1: Fumonisin B1 
FB2: Fumonisin B2 
OTA: Ochratoxin A 
ZEA: Zearalenone 
LC: Liquid chromatography 
QC: Quality control 
DON-M: Labelled deoxynivalenol  
FB1-M: Labelled fumonisin B1  
ZEA-M: Labelled zearalenone  
AFLAB1-M: Labelled aflatoxin B1 





Sixty-four complete commercial extruded dry cat foods were purchased from stores in the 
province of Bologna (Italy). 
The products included 6 diet obesity, 7 diet renal, 6 diet gastrointestinal, 5 grain-free, 5 kitten-
low, 5 kitten-premium, 5 senior-low, 5 senior-premium, 20 adult-low cat foods. 
Samples were categorized also in two main groups, based on two price categories considered: 
 
 premium pet food for cats: 6 diet obesity, 7 diet renal, 6 diet gastrointestinal, 5 grain-free, 
5 kitten-premium, 5 senior-premium; 
 standard pet food for cats: 5 kitten-low, 5 senior-low, 20 adult-low cat foods. 
 
Samples (already pulverized in ―Animal Productions and Food Safety Service‖ set in the 
DIMEVET) were stored in plastic containers in freezer under dark conditions.  
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4.2.3 Glassware and consumables 
 
 Class A graduated glassware (cylinders, beakers, flasks, glass pipettes); 
 Falcon tubes; 
 Glass test tubes; 
 Millipore filters Amicon Ultra 0.5 mL 3K; 
 2 mL glass vials with cap. 
 
 
4.2.4 Lab equipment 
 
 Analytical balance (trueness of ± 0.001 g); 
 Vortex Scientific Velp; 
 Hettich refrigerated centrifuge; 
 Gilson P5000, P1000, P200 and P20 pipettes; 
 LC-MS/MS system, consisting of a Waters ACQUITY UPLC pump equipped with a 
Waters ACQUITY BEH C18 column, coupled to a Waters Quattro Premier XE tandem 
mass spectrometer (Waters, Milford MA, USA). 
 
 




 DON: Deoxynivalenol, purity ≥98% (Sigma-Aldrich. St.Louis, USA);  
 AFLAB1: Aflatoxin B1 from Aspergillus flavus, purity ≥98% (Sigma-Aldrich, St.Louis 
USA);  
 AFLAB2: Aflatoxin B2 from Aspergillus flavus, purity ≥98% (Sigma-Aldrich, St.Louis 
USA);  
 AFLAG1: Aflatoxin G1 from Aspergillus flavus, purity ≥98% (Sigma-Aldrich, St.Louis 
USA);  
 AFLAG2: Aflatoxin G2 from Aspergillus flavus, purity ≥98% (Sigma-Aldrich, St.Louis 
USA);  
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 FB1: Fumonisin B1 from Fusarium moniliforme, purity ≥98% (Sigma-Aldrich, St.Louis 
USA);  
 ZEA: Zearalenone, purity ≥99% (Sigma-Aldrich, St.Louis USA);  
 OTA: Ochratoxin A from Tetromyces albertensis, purity ≥98% (Sigma-Aldrich, St.Louis 
USA).  
 T2: T-2 toxin, (Sigma-Aldrich, St.Louis USA); 
 HT2: HT-2 toxin (Orsell SRL, Modena Italy); 
 Labeled DONC13: U-[13C15]-Deoxynivalenol, purity 99.5% (Biopure, Tulln Austria);  
 Labeled AFLAB1: U-[13C17]-Aflatoxin B1, purity 99% (Biopure, Tulln Austria);  
 Labeled FB1C13: U-[13C34]-Fumonisin B1, purity 97.8% (Biopure, Tulln Austria);  
 Labeled ZEAC13: U-[13C15]-Zearalenone, purity 99.2% (Biopure, Tulln Austria);  





All the solvents used for mass spectrometric analysis were LC-MS grade, while those used for 
the extraction phase were HPLC grade. 
 
 Methanol (Sigma-Aldrich, St Louis MO, USA); 
 Acetonitrile (VWR); 
 Ultrapure water (18.2 MΩ /cm) was obtained via a Human Power I lab water 
purification system (Human Corp., Seoul, South Korea); 
 Acetic acid (Sigma-Aldrich, St Louis MO, USA); 
 Formic acid (Fluka); 





The standard solutions used for the preparation of the QC and calibration samples were 
prepared according to the following procedure: 
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 Stock solutions: for each analyte a 20 ppm stock solution was prepared dissolving 1 mg 
of standard in 50 μL of solvent. Dilution is carried out in acetonitrile. 
 Standard: 250 μL are taken from the "stock solution" solution at 20 ppm and is brought 
to volume in 5 mL of methanol in a volumetric flask, resulting in a final concentration of 
1 ppm. 
 Labeled standard: 250 μL is taken from the commercial solution of labeled standards at 
25 ppm and is brought to volume in 1 mL of methanol in a volumetric flask, resulting in 





 Solution for extraction (ACN/H2O 50:50): 50 mL of acetonitrile, 50 mL of water are 
mixed stirred and stored in a refrigerator. 
 
 
4.2.6 Sample preparation 
 




0.5 grams of feed sample was weighed in a beaker fortified with 100 μL of the internal standard 
solution and kept at rest for 15 minutes. Then 5 mL of the extraction solution (ACN/H2O 
50:50) were added to the sample and the whole is kept on a magnetic stirrer for 15 minutes (two 
phases are formed: the sediment and the surnatant one). Then 500 μL were taken from the 
supernatant and transferred to a Millipore filter and centrifuged for 30 minutes at 14000 rpm and 









































The method was set-up and optimized from a protocol of Gazzotti et al. (Gazzotti et al. 2015). 
 
The chromatographic conditions for all analytes except for DON are described in table 33. 
 Strong solution: water, acetonitrile and methanol in the proportions of 30:30:40, with 
0.2% formic acid; 

















Table 33. Chromatographic conditions for all analytes, except for DON and labeled DON. 
  
Mobile Phase A Water + 0.1% formic acid 
Mobile Phase B Methanol + 0.1% formic acid 
Gradient T0 95% A - 5% B  
 T2 
T4 
95% A - 5% B 
90% A - 10% B 
 T12 25% A - 75% B 
 T12,1 1% A - 99% B 
 T14 1% A - 99% B 
 T14,1 95% A - 5% B 
 T16 95% A - 5% B 
Flow 0.42 mL/min 
Injection volume 10 µL 
Temperature 40 °C 
 133 
The chromatographic conditions for DON and labeled DON are described in table 34. 
 Strong solution: water, acetonitrile and methanol in the proportions of 30:30:40; 















Mobile phase A Ammonium acetate 5 mM in Water 
Mobile phase B Methanol 
Gradient 
T0 99% A - 1% B 
T1 95% A - 5% B 
T2 25% A - 75% B 
T2.10 1% A - 99% B 
T4 99% A - 1% B 
T6 99% A - 1% B 
Flow 0.3 mL/min 
Injection Volume 10 µL 


























Ionisation mode ESI positive 
Capillary voltage 3.0 kV 
Cone Component depends V 
Source temperature 130°C 
Desolvation temperature 450°C 
Desolvation gas flow 446 L/hour 
Cone gas flow 43 L/hour 
Multiplier 690 
LM 1 resolution 15.0 
HM 1 resolution 15.0 
Ion energy 1 0.2 
LM 2 resolution 11.0 
HM 2 resolution 11.0 
Ion energy 2 1.0 
CID gas Argon p = 7.34 x 10-3 mbar purity > 99.998% 
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Compounds Precursor Product Cone (V) CE (eV) 
Aflatoxin B1 313.2 
241.3 45 36 
285.3 45 22 
Aflatoxin B2 315.05 
259.1 45 38 
287.1 45 33 
Aflatoxin G1 329.1 
243.3 45 26 
283.3 45 24 
Aflatoxin G2 331.1 
245.2 46 39 
313.25 46 33 
Deoxynivalenol 297.25 
231.25 19 12 
249.2 19 10 
Fumonisin B1 722.2 
334.5 52 45 
352.5 52 43 
Fumonisin B2 706.3 
318.5 50 40 
336.5 50 40 
Zearalenone 319.3 
185.2 20 30 
187.2 20 12 
283.2 20 12 
Ochratoxin 404.15 
221.2 25 25 
239.2 25 14 
T-2 toxin 489.2 
245.1 36 27 
387.0 36 22 
HT-2 toxin 447.25 
285.3 36 22 




255.4 45 38 




216.4 18 18 
263.4 18 13 




356.6 52 45 




199.4 17 18 







Table 36. Theoretical mono-isotopic masses of the precursor ions and product ions. 
 
 
4.2.8 Statistical analysis 
 
A statistical analysis of variance using Student‘s t-test was conducted on concentrations of the 
various mycotoxins determined in premium and standard dry food for cats: the aim was to 
identify any statistically significant differences between the two price categories evaluated.  







232.4 26 38 




260.3 40 28 
406.2 40 23 
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4.3 RESULTS  AND  DISCUSSION 
 
4.3.1 Measurement range 
 
The following method shows the quantification limit (LOQ) and detection limit (LOD) for each 
molecule expressed in ppb (Table 37). 
 
Compounds LOQ LOD 
Aflatoxin B1 3 1 
Aflatoxin B2 3 1 
Aflatoxin G1 3 1 
Aflatoxin G2 3 1 
Deoxynivalenol 3 1 
Fumonisin B1 3 1 
Fumonisin B2 3 1 
Zearalenone 5 2 
Ochratoxin 5 2 
T-2 toxin 10 5 
HT-2 toxin 20 5 
 
Table 37. Quantification limit (LOQ) and detection limit (LOD) for each molecule expressed in ppb. 
  
 138 
4.3.2 Concentration of mycotoxins in commercial pet food for cats 
 
Data relating to frequency of positive/negative/trace samples and different mycotoxin 
concentration in the nine pet food for cats categories were shown in the graphs below. 
 
  Premium diet obesity samples 
 
 
Graph 5. Diet obesity pet food for cats. Frequency of positive, negative, 
trace samples (on the left); mycotoxins concentration (on the right). 
 
In premium diet obesity samples (n=6): 
 
 AFB1, AFB2, AFG1, AFG2, OTA were not detected;  
 with regards to FB1 and FB2 all samples were found positive; two samples 
exceeded the guidance values for FB1+FB2, showing 7494.4 ppb and 7932.6 ppb 
respectively; 
 small amounts of ZEA and DON were found: in the 16.7% of the samples no 
ZEA was detected, while 83.3% of the samples were positive ranging from 5 to 
112 g/Kg; while in the 33.3% of the samples no DON was found and the 
remaining part was found positive (with a mean value of 88.1 ppb); 
 T-2 and HT-2 toxins presented the 16.7% traces, while the other part was 
negative (graph 5).  
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Graph 6. Diet renal pet food for cats. Frequency of positive, negative,  
trace samples (on the left); mycotoxins concentration (on the right). 
 
In premium diet renal pet food for cats (n=7): 
 
 AFB2, AFG1, AFG2, OTA were not present; AFB1 exceeded the set limit in one 
sample (17.4 ppb) and was present in traces in two samples; 
 FB1 and FB2 were found in all samples, with mean values of 325.9 and 448.4 
ppb respectively, not exceeding the guidance values specified in the above-
mentioned recommendation; 
 14.9% of samples were negative for ZEA, while the 42.9% were at trace level and 
the other part was positive (mean value of 88.6 ppb);  
 the major part of samples were positive to DON (85.7%, mean value of 129.2 
ppb), while 14.3% contained traces; 
 57.1% of samples were negative for T-2 toxin, while the remaining part 
contained traces; the majority of samples were negative for HT-2 (85.7%), while 
14.3% contained traces (graph 6).  
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Graph 7. Diet gastrointestinal pet food for cats. Frequency of positive,  
negative, trace samples (on the left); mycotoxins concentration (on the right). 
 
In premium diet gastrointestinal pet food for cats (n=6): 
 
 AFB1, AFB2, AFG1, AFG2, OTA, HT-2 toxin were not present; 
 FB2 was found in all samples, representing the most abundant mycotoxin; while 
FB1 was only present in the half of samples; 
  ZEA and DON were present in small traces. Thus 33.3% of samples were 
equally positive, negative and presented trace levels for ZEA; while half of 
samples were positive to DON;  
 More interestingly, although the half of samples were negative to T-2 toxin, and 
also with traces presented in the 33.3% of cases, two samples out of six were 
positive displaying respectively a content of 13.2 and 69.6 g/Kg respectively 
(graph 7). The latter value did not conform to the UE Recommendation 
2016/1319, which suggested a maximum level for T-2+HT-2 toxin at 50 g/Kg. 
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 Premium grain-free samples 
 
 
Graph 8. Grain-free pet food for cats. Frequency of positive, negative,  
trace samples (on the left); mycotoxins concentration (on the right). 
 
In premium grain-free pet food for cats (n=5): 
 
 AFB1, AFB2, AFG1, AFG2, HT-2, T-2 toxins were not present. 
 ZEA and OTA were equally negative in 80% of the samples, while were present 
in trace quantities in 20% of them; 
 DON traces were found in 40% of the samples, while the other part was negative 
(graph 8).  
 
As expected the grain-free category showed the lowest mycotoxin contamination, 
displaying low levels of fumonisins (FB1+FB2). 
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 Standard kitten low 
 
Graph 9. Kitten low pet food for cats. Frequency of positive, negative,  
trace samples (on the left); mycotoxins concentration (on the right). 
 
In standard kitten low pet food for cats (n=5): 
 
 no amount of AFB1, AFB2, AFG1, AFG2, HT-2 toxins was found; 
 All samples were positive to DON ranging from 3 to 72.9 g/Kg; 
 ZEA was found in 40% of samples with a mean value of 11.3 g/Kg; 
 FB1 and FB2 were detected in all samples, with values in accordance to the EU 
Recommendation guidelines; 




 Premium kitten samples 
 
Graph 10. Kitten premium pet food for cats. Frequency of positive, negative, 
 trace samples (on the left);mycotoxins concentration (on the right). 
 
In premium kitten pet food for cats (n=5):  
 
 no amount of AFB2, AFG1, AFG2, OTA, HT-2 toxins was found; 
 FB1 and FB2 were present in all samples, displaying values in accordance to the 
EU Recommendation guidelines; 
 60% of the samples were positive for DON, ranging from 10.7 to 62.4 g/Kg; 
 Only one sample out of five was positive for ZEA, showing a content of 25.5 
g/Kg; 
 Furthermore one sample was positive to T-2 toxin displaying a content of 27.9 
g/Kg, which represented more than the half value suggested by UE 




 Standard senior low 
 
 
Graph 11. Senior low pet food for cats. Frequency of positive, negative, 
 trace samples (on the left); mycotoxins concentration (on the right). 
 
In standard senior low pet food for cats (n=5): 
 
 AFB2, AFG1, AFG2, OTA were not detected;  
 AFB1 was present in trace amount in the 40% of the samples, while the other 
part was negative. 
 80% of the samples were positive to ZEA, ranging from 11.5 to 31 g/Kg; 
 DON was found in all samples, with a mean value of 115 g/Kg; 
 T-2 and HT-2 toxins were equally negative in the 80% of samples, while the 
remaining part contained traces; 
 FB1 and FB2 were present in all samples, with values in accordance to the EU 
Recommendation guidelines (graph 11). 
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 Premium senior 
 
 
Graph 12. Senior premium pet food for cats. Frequency of positive, negative,  
trace samples (on the left); mycotoxins concentration (on the right). 
 
In premium senior pet food for cats (n=5): 
 
 AFB2, AFG1, AFG2, OTA were not detected; 
 AFB1 trace was present only in one sample, the remaining samples were 
negative. 
 80% of the samples were positive to ZEA, ranging from 11.4 to 58.1 μg/Kg;  
 DON was found in all samples, with a mean value of 224.6 μg/Kg; 
  T-2 and HT-2 toxins were both negative in the 80% of the samples, the 
remaining part contained traces; 
 FB1 and FB2 were found in 80% of the samples, these values were in accordance 
with the EU recommendation guidelines, a trace amount was detected in one 
sample (graph 12). 
  
 146 
 Standard adult low 
 
Graph 13. Adult low pet food for cats. Frequency of positive, negative,  
trace samples (on the left); mycotoxins concentration (on the right). 
 
In standard adult low pet food for cats (n=20): 
 
 AFB2, AFG1, AFG2 were not present; two samples exceeded the maximum 
value set for AFB1, with 18.4 μg/Kg  and 16.5 μg/Kg respectively. 
 30% of samples were positive to ZEA, with a mean value of 13.9 μg/Kg;  
 DON was found in all the samples, with a mean value of 273.9 μg/Kg; 
 T-2 was present in 30% of the samples with a mean value of 33.2 μg/Kg, which 
represented more than the half of the guidance value set by EU 
Recommendation; HT-2 toxin was present in trace quantities in 10% of the 
samples, while the remaining part was negative; 
 FB1 and FB2 were present in 95% of the samples, with values in accordance to 
the EU Recommendation guidelines; 
 although 70% of samples were negative for OTA, 20% presented traces and two 
samples were positive with 14 μg/Kg and 5.1 μg/Kg (graph 13).  
The first one exceeded the guidance value set by the EU Recommendation. 
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The present study showed that four premium samples for adult cats and three standard samples 
for adult cats exceeded the guidance values for some mycotoxins.  
Surprisingly two premium ―diet obesity‖ samples, one premium ―diet renal‖ sample and one 
premium ―diet gastrointestinal‖ sample exceeded the guidance values/limit for FB1+FB2, AFB1 
and T2 respectively. 
The standard adult low category displayed that three samples exceeded the limit/guidance values 
for AFB1 (two samples) and OTA. 
This fact could represent a critical point, since in this study some samples (designed with a 
specific formulation for cats diagnosed with pathological conditions or addressed to a selected 
age group) exceeded the guidelines/limit for some mycotoxins. Contaminations could also cause 
nutritional deficiencies despite a correct diet formulation (Di Cerbo et al. 2017).  
 
This research also revealed that: 
 one of the most common co-contamination was represented by ZEA, DON, FB1+FB2, 
since these mycotoxins were the most detected ones in the samples analysed; 
 AFB2, AFG1, AFG2 were not present in any of these 9 categories; 
 all samples contained quantified amounts of at least two types of mycotoxins, FB1 and 
FB2; 
 most of the samples from the diet obesity-, kitten low-, senior low-, and senior premium- 
category displayed a contamination by four different types of mycotoxins; 
 most of the samples from the diet renal-, diet gastrointestinal-, and kitten premium- 
category revealed a contamination by five different types of mycotoxins; 
 as expected, premium grain-free samples, which did not contain starch from cereals but 
often from legumes and potatoes, represented the category with the lowest 
contamination level. 
 
The co-occurrence of ZEA, DON, FB1+FB2 fairly agree with other studies conducted on pet 
food. A study from Oliveira et al. describing the occurrence of aflatoxins and fumonisins in corn 
intended for pet feed industry, revealed that fumonisins were detected in all samples evaluated 
(Oliviea et al. 2016). 
Also a study from Błajet-Kosicka et al. 2014 described that DON and ZEA were identified in all 
dry pet food for cats and dogs analysed (Błajet-Kosicka et al. 2014). 
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Differently from a research monitoring mycotoxins in dry dog food (Gazzotti et al. 2015), this 
study showed an AFB1 contamination in 12.5% of samples evaluated. Moreover, as previously 
described, in the present work three samples exceeded the limit for AFB1 in pet food. 
 
Regarding the statistical analysis ZEA was found with values significantly higher in premium 
products than in standard ones. 
While DON was found with values significantly higher in standard products than premium ones. 
So the present study pointed out that a high category price, such as for premium dry food for 














In this research an LC-MS/MS method with IAC clean-up was developed to detect zearalenone, 
α-zearalanol, ß-zearalanol, α-zearalenol, ß-zearalenol and zearalanone simultaneously in bovine 
hair. 
The method was also validated for three analytes (zearalanone,α-zearalanol, ß-zearalanol) in 
accordance with Decision 2002/657/EC, showing satisfactory recoveries and linearity, good 
precision, trueness and high sensitivity. Moreover the method was robust and stable, since the 
extracts could be stored in a freezer for one week before they were going to be analysed.  
With this approach zearalenone and relative metabolites in bovine hair can be effectively 
monitored.  
However the method also seemed capable to detect zearalanone, α-zearalanol, ß-zearalanol, 
zearalenone, α-zearalenol and ß-zearalanol in human hair in a lower range level. 
For this a one-day validation was performed for all six analytes, showing reasonable results, 
although passable values in term of precision and trueness at 0.5 GV for α-zearalanol, α-
zearalenol, ß-zearalenol and recoveries were obtained.  
No previous study on zearalenone and related metabolites residues in bovine and human hair 
using LC-MS/MS has been published, thus the present work evaluated the suitability of this non 
conventional matrix for biomonitoring studies.  
The exploring the potential of hair for biomonitoring studies of zearalenone and metabolites 
exposure is still in its initiation phase. Hair is a durable matrix that shows various benefits for 
biomonitoring, such as low cost, easy collection, non-invasive, easy storage and information 
about short and long-term exposure. 
The set-up method on bovine and human hair can provide useful information regarding 
zearalenone and metabolites occurrence in feedstuffs and foodstuffs, which can represent a huge 
impact on agri-food sector and economy. Moreover using livestock for biomonitoring may 
represent an indirect method to better understand the contamination levels occurring in animal 
products, that can be a relevant part of human diet. 
Furthermore this research could represent a useful tool both evaluating natural feed 
contamination or detect not legal use of α -zearalanol in bovine, both performing a first 
inventory of the occurrence of RALs in bovine and human hair as biomarkers for ZEA exposure 
in future studies. 
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The research study on pet food for cats showed that one of the most common co-contamination 
was represented by ZEA, DON, FB1+FB2.  
Futhermore four premium samples exceeded the guidance values/limit for FB1+FB2, AFB1 and 
T2; while three samples from standard category exceeded the limit/guidance values for AFB1 
(two samples) and OTA. 
However these data highlighted the necessity to further investigate the potential synergistic 
effects that could occur. 
Taking into account of the chronic exposure to which a cat is potentially exposed to when it is 
fed contaminated food for a long period of time, it is desirable to encourage pet food 
manufacturers to test for mycotoxins. 
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